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SUMMARY 
 
Expediting a diagnosis of tuberculosis in children, particularly those who are 
immunocompromised due to HIV/AIDS, is essential, as they are vulnerable to develop severe 
forms of disease due to their immature or compromised immune systems. A significant 
percentage of children (8 to 10%) with TB have TB lymphadenitis, in isolation, or in 
combination with other disease manifestations.  
Fine needle aspiration biopsy (FNAB) is a simple and minimally invasive procedure 
well tolerated by children. It may be performed as an outpatient procedure by clinicians as 
well as nurses, and excellent results can be achieved with training in the correct procedure. 
The aim of this dissertation was to demonstrate that FNAB may contribute 
significantly to the diagnosis of mycobacterial lymphadenitis, with particular reference to 
children TB suspects. We first established that TB lymphadenitis is a common clinical 
problem in children in TB endemic areas and that FNAB is an efficient simple and effective 
diagnostic modality in children with peripheral lymphadenopathy. 
We then proceeded to document the diagnostic yield and time to diagnosis of FNAB 
compared to conventional laboratory specimens collected in children. 
We investigated the value of additional diagnostic modalities such as autofluorescence 
in improving the ability of cytology to make a definitive diagnosis of mycobacterial infection 
based on cytomorphology and identification of the organism.  
In countries where organisms such as  Mycobacterium bovis BCG and non-
tuberculous mycobacteria are prevalent, culture with subsequent speciation is essential. The 
amount of material harvested during FNAB is minuscule, and requires immediate bedside 
inoculation for optimal yields.  
We developed an inexpensive and effective transport medium to facilitate 
mycobacterial culture from FNAB, even if this is collected at an outside facility. It is ideally 
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suited for use in clinics and rural hospitals as it is stable at room temperature, maintains 
viability of the organism for seven days, and the closed lid format reduces contamination.  
Mycobacterial culture even using liquid-based media, takes up to 6 weeks, and this 
delay is unacceptable particularly in children. We developed a Nucleic Acid Amplification 
Technique (NAAT) using High Resolution Melt Analysis and applied this novel technique to 
FNAB specimens submitted in transport medium. Although sensitivity remained suboptimal, 
the technique is highly specific, simple and rapid. Its use could be incorporated into routine 
microbiology laboratories, to assist with rapid diagnosis while cultures are pending. 
We collected a solid body of evidence, which will promote the use of FNAB in 
suspected mycobacterial lymphadenopathy, particularly in children in resource-limited 
countries. The utilisation of the diagnostic methods identified will expedite speciation and 
allow early and appropriate initiation of therapy. This is in keeping with Millennium 
Development Goal 6: to combat TB by early detection of new cases and effective treatment. 
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OPSOMMING 
 
Kinders met tuberkulose (TB), en veral diegene met gekompromiteerde immuniteit as gevolg 
van MIV/VIGS, het ‘n verhoogde neiging om ernstige siektebeelde te ontwikkel vanweë hul 
onvolwasse of gekompromiteerde immuunsisteme. ‘n Spoedige diagnose van TB in kinders is 
dus noodsaaklik. ‘n Betekenisvolle persentasie van kinders (8 tot 10%) met TB het TB 
limfadenitis met of sonder meegaande ander siekteverskynsels. 
Fynnaaldaspirasiebiopsie (FNAB) is ‘n eenvoudige en minimale indringende 
prosedure wat geredelik deur kinders aanvaar word. Geneeshere en verpleegkundiges wie 
toepaslike opleiding in die uitvoering van FNAB ontvang het, kan die prosedure op 
buitepasiënte uitvoer en uitstekende resultate behaal. 
Die doel van hierdie studie was om aan te toon dat FNAB betekenisvol kan bydra tot 
die diagnose van mikobakteriële limfadenitis in veral kinders met vermoedelike TB. Daar was 
eerstens bevestig dat TB limfadenitis ‘n algemene kliniese probleem is in kinders in TB 
endemiese areas en dat FNAB ‘n doeltreffende, eenvoudige en effektiewe diagnostiese 
modaliteit is in kinders met perifere limfadenopatie. 
Vervolgens was FNAB se diagnostiese opbrengs en die tydsverloop tot diagnose 
vergelyk met dié van konvensionele laboratoriummonsters wat in kinders verkry word.  
Die bydrae van verdere diagnostiese modaliteite soos outofluoressensie tot ‘n 
verbetering in sitologie se rol in die diagnose van mikobakteriële infeksie, soos gebaseer op 
sitomorfologie en identifisering van organismes, is ondersoek. 
In lande waar organismes soos Mycobacterium bovis BCG en nie-tuberkuleuse 
mikobakterië heersend is, is kultuur en spesiebepaling noodsaaklik. Die hoeveelheid materiaal 
wat met FNAB verkry word is baie min en vereis onmiddellike okulasie vir die beste 
resultate. 
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Tydens hierdie studie is ‘n goedkoop en effektiewe vervoermedium ontwikkel om 
mikobakteriële kultuur van FNAB verkreë monsters te fasiliteer, selfs al is die monster vanaf 
‘n buite fasiliteit bekom. Die vervoermedium is baie geskik vir gebruik in klinieke en 
plattelandse hospitale. Dit is stabiel by kamertemperatuur, handhaaf lewensvatbaarheid van 
organismes vir sewe dae, en die geslote dekselformaat verminder kontaminasie. 
Mikobakteriële kultuur neem tot ses weke, selfs met die gebruik van 
vloeistofgebaseerde mediums. Sodanige vertraging in die diagnose is veral in kinders 
onaanvaarbaar. Tydens hierdie studie is ‘n Nukleïnsuur Amplifikasietegniek ontwikkel deur 
die aanwending van Hoë Resolusie Smeltanalise en is hierdie nuwe tegniek toegepas op 
FNAB verkreë monsters wat in die vermelde vervoermedium versamel was. Alhoewel 
sensitiwiteit nie optimaal was nie, is die tegniek baie spesifiek, eenvoudig en vinnig. Dit kan 
in roetine mikrobiologie laboratoriums gebruik word om vinnige diagnose te bewerkstellig 
terwyl daar gewag word vir die kultuur se resultaat. 
 Hierdie studie bied omvattende bewys ter ondersteuning van die gebruik van FNAB 
in veral kinders met vermoedelike mikobakteriële limfadenopatie in lande met beperkte 
hulpbronne. Die toepassing van die diagnostiese metodes wat in hierdie studie identifiseer is 
sal spesiebepaling bespoedig en vroegtydige en toepaslike behandeling verseker. Dit stem 
ooreen met Millennium Ontwikkelingsdoelwit 6: om TB te beveg deur vroeë opsporing van 
nuwe gevalle en effektiewe behandeling. 
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CHAPTER 1 
INTRODUCTION 
Tuberculosis (TB) was declared a global emergency in 1993 by the World Health 
Organisation (WHO) when it was estimated that a third of the world's population is infected 
with TB.1  The developing world bears the brunt of this disease burden; 95% of TB cases and 
98% of TB deaths occur in the developing world, with sub-Saharan Africa reporting the 
highest TB incidence in the world.2 In 2005 there were an estimated 8.8 million new TB cases 
globally and 7.2 million of these were in Asia and sub-Saharan Africa. Despite efforts to 
contain the epidemic new TB cases increased by 6% between 2000 and 2005, predominantly 
in sub-Saharan Africa and Asia. 
The problem is compounded by the parallel human immunodeficiency virus (HIV) 
pandemic with 33.2 million adults and children living with HIV in 2007, and 68% of these in 
sub-Saharan Africa.3  Infection with the HIV virus is estimated to increase the lifetime risk of 
a patient infected with M tuberculosis of developing TB by 10 fold to 50%.4 South Africa 
with 5.5 million people leads the world in the number of patients living with HIV, as well as 
TB/HIV co-infection.5  
 
TB in childhood 
TB is a major cause of childhood morbidity and mortality in developing countries.6, 7  It is 
estimated that 11% of the 8.3 million new TB cases diagnosed globally in 2000 occurred in 
children,8 and in endemic areas children contribute at least 15-20% of the total disease 
burden.9 In the Western Cape Province, a high burden region in South Africa, the TB 
notification rate in children less than 14 years of age was reported at 620 /100,000 in 2007.10 
Official child TB figures almost certainly represent a gross underestimate due to 
problems in obtaining an accurate diagnosis in resource-limited settings, poor record-keeping 
and under reporting.8 Children rarely have sputum smear-positive TB, although this reduces 
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the risk of actively spreading the disease, it makes it more challenging to establish a definitive 
diagnosis. Expectorated sputum specimens are difficult if not impossible to obtain in children 
under the age of 7-8 years.  Collection of induced sputum and gastric aspirate specimens are 
possible, but difficult to collect and reported bacteriological yields are low (30-40%).8, 11 
A clinical diagnosis of TB in children is problematical and although chest radiography 
is regarded as the most practical test to provide a reasonably accurate diagnosis of 
intrathoracic TB in children with suspicious symptoms, it has multiple limitations.12 In HIV-
infected children the diagnosis of both intrathoracic and extra thoracic TB is difficult due to 
underlying chronic pathology such as lymphocytic interstitial pneumonitis (LIP) or 
bronchiectasis and opportunistic infections. Chest radiography can also not provide diagnostic 
confirmation in children with extra thoracic TB. In a study in the Western Cape, South Africa 
10.7% of children treated for active TB had extra thoracic disease manifestations only; 
cervical TB lymphadenitis was the most common condition in these children being present in 
48.6%. TB lymphadenitis is a common cause of persistent cervical adenopathy in TB endemic 
areas. Persistent peripheral lymphadenopathy in HIV-infected children is a criterion for the 
clinical classification of HIV itself.  It may also be associated with multiple other pathological 
entities, from infections to neoplasia. 
Mycobacterium tuberculosis is not the only mycobacterial organism which involves 
peripheral lymph nodes. In developed countries non-tuberculous mycobacteria (NT M) is the 
commonest mycobacterial organism isolated and BCG vaccination may be associated with 
local complications such as abscess formation at the vaccination site and regional 
lymphadenitis. It is also the most common manifestation of immune reconstitution syndrome 
(IRIS) if vaccinated HIV-infected infants are commenced on highly active anti-retroviral 
therapy (HAART). It is therefore important to develop methods that will provide a rapid and 
definitive mycobacterial diagnosis in children with persistent peripheral lymphadenopathy. 
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Fine needle aspiration biopsy (FNAB) is a specimen collection technique which is 
widely used in the diagnosis of palpable masses including peripheral lymphadenopathy. Its 
value in the diagnosis of mycobacterial lymphadenitis in adults is well documented. FNAB is 
a simple effective and safe modality for obtaining a representative sample of material from a 
lymph node and the diagnosis of mycobacterial adenitis can be confirmed utilising a number 
of different investigations, including cytomorphology, specific stains to identify the organism, 
culture and polymerase chain reaction (PCR).   
FNAB is not widely used for the diagnosis of mycobacterial disease in children. As 
this is a rapid and minimally invasive technique which can be performed on an outpatient 
basis, in a primary health care setting it is ideal for use in resource-limited countries with the 
highest incidence of mycobacterial disease as well as HIV infection. 
 
Study objectives  
The main study objective was to evaluate and develop laboratory-based diagnostic techniques 
to establish a rapid, accurate and cost effective diagnosis of mycobacterial lymphadenitis in 
children, using FNAB as the sampling method.We applied a stepwise approach using multiple 
studies with specific aims to achieve this objective. 
 
To establish that TB lymphadenitis is a common clinical problem in children from TB 
endemic areas 
This aim is addressed in chapter 3:  
A prospective community-based study documented the contribution of TB 
lymphadenitis to persistent lymphadenopathy among children who present to primary health 
care clinics with persistent cervical adenopathy in a TB endemic area. 
 
To evaluate the diagnostic utility and feasibility of FNAB in a resource limited setting 
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These aims are addressed in chapter 4:  
A laboratory-based retrospective study documented FNAB adequacy rates among 
various health care professionals who performed the procedure and described the spectrum of 
pathology seen. 
A laboratory-based retrospective study compared FNAB to more established specimen 
collection.  
A laboratory-based retrospective study evaluated the utility of FNAB in HIV-infected 
children (supplementary manuscript). 
 
To determine optimal methods for cytopathological diagnosis of mycobacterial disease 
These aims are addressed in chapter 5 and 7: 
A prospective laboratory-based study conducted in adults and children to determine 
the value of incorporating autofluorescence into cytopathological evaluation of lymph node 
aspirates in patients with suspected mycobacterial disease. 
A prospective laboratory-based study in children assessing the ability of FNAB to 
diagnose mycobacterial lymphadenitis in children, using cytomorphology, autofluorescence 
on Papanicolaou stained smears, Ziehl-Nielsen (ZN) staining and/or culture. 
A retrospective laboratory-based study to assess cytomorphological patterns of M. 
bovis BCG and M. tuberculosis on FNAB (supplementary manuscript). 
A retrospective laboratory-based study to evaluate fluorescence microscopy in the 
diagnosis of mycobacterial infection using FNAB samples and a rewind able (power 
independent) LED light source (supplementary abstract). 
 
To explore novel methods for optimal culture-based and molecular diagnosis  
These aims are addressed in chapters 6 and 7: 
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A prospective pilot study, collecting residual material from fine needle aspiration 
biopsy in 200 µL of sterile water, to investigate the feasibility of utilising PCR amplification 
techniques with fractionation in agarose gel  and visualisation using ethidium bromide 
directly from FNAB samples (supplementary study). 
A prospective hospital-based study to assess the value of using a simple mycobacterial 
transport medium for bedside inoculation of FNAB specimens. 
A prospective hospital-based study utilizing FNAB combined with High Resolution 
Melt Analysis to reduce diagnostic delay in patients mycobacterial adenitis. 
A simplified technique using FNAB and collection of residual material on FTA paper 
and real-time PCR/HRM for the diagnosis of mycobacterial infection (supplementary 
manuscript in progress). 
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CHAPTER 2 
 
COMPREHENSIVE LITERATURE REVIEW 
 
 
Fine needle aspiration Biopsy (FNAB) - an undervalued diagnostic modality in pediatric  
mycobacterial disease 
Colleen A Wright,  Rob Warren, Ben J Marais 
International Journal of Tuberculosis and Lung Disease – in press 
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Unstructured summary 
Mycobacterial disease, particularly tuberculosis, is an escalating problem in developing 
countries, fuelled by the parallel HIV pandemic. In tuberculosis (TB) endemic countries 
children carry a very high burden of disease, which may be unrecognised due to the difficulty 
in making a diagnosis based on clinical, radiological or laboratory methods.  One of the main 
hurdles is the difficulty of obtaining adequate specimens for bacteriological confirmation of 
disease in children. 
TB lymphadenitis is the most common extra-pulmonary manifestation of TB and up to 
up to 22% of children with persistent cervical lymphadenopathy and no local cause may have 
TB adenitis Therefore fine needle aspiration biopsy (FNAB), which is a simple and safe 
outpatient procedure that can be performed by nurses in resource-limited settings and 
provides material for direct microscopy as well as culture and susceptibility testing, provides 
an excellent opportunity to obtain bacteriologic confirmation.  However, it remains a greatly 
underutilized specimen collection modality. 
This review provides a comprehensive overview of the diagnostic difficulties faced in the 
diagnosis of paediatric TB in resource-limited settings and suggests ways to utilise FNAB 
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as a practical modality for the rapid and effective diagnosis of mycobacterial disease in the 
significant subset of patients who present with peripheral lymphadenopathy. It also provides 
detail on how best to perform the technique and suggests ways of making it more widely 
available in resource-limited settings that carry the brunt of the paediatric TB disease burden. 
 
The scale of the problem 
Mycobacterium tuberculosis  
In 2005, there were an estimated 8.8 million new tuberculosis (TB) cases globally, 7.4 million 
in Asia and sub-Saharan Africa. More than 4000 people died every day from TB related 
illnesses in that year, with  the developing world bearing the brunt of this massive disease 
burden; 95% of TB cases and 98% of TB deaths occurred in the developing world.1  What is 
even more alarming is the projected scale of the epidemic to come; the World Health 
Organization (WHO) has estimated that between 2000 and 2020 1 billion people will be 
newly infected with M. tuberculosis, resulting in 200 million TB cases and 35 million deaths.2 
TB is a major cause of childhood morbidity and mortality in developing countries.3-4  
Accurate figures on the extent of paediatric TB are not available due to inadequate health 
information systems in endemic countries and the limited attention paid to children who 
contribute little to TB transmission within affected communities.  WHO estimates of disease 
incidence are based on sputum smear-positive cases, but more than 80% of children with TB 
are sputum smear-negative. Indications are that children contribute at least 15-20% of the 
total disease burden in endemic areas and that they suffer severe TB related morbidity and 
mortality.5  Recognition of this high disease burden and the fact that highly effective 
treatment is available has led to increased emphasis on the diagnosis and management of 
paediatric TB. WHO research priority guidelines for paediatric TB identified the evaluation of 
new techniques to improve the diagnosis and management of paediatric TB as an urgent 
research priority.6  
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According to 2005 WHO figures, South Africa, despite its relatively good 
infrastructure and health care services, reported a TB incidence of 600/100,000 
population/year with a mortality rate of 71/100,000 population/year.1 The Western Cape 
Province, a very high burden region in 2007 reported the adult TB incidence as 1005.7 per 
100,000 compared to the National incidence rate of 739.6/100,000 population.7 In 2007 the 
Western Cape Department of Health reported a TB notification rate of 620 per 100 000 in 
children (0-14 years of age).8  A prospective observational study conducted in Cape Town 
demonstrated that children less than 13 years of age contributed 13.7% of the total TB 
caseload with a calculated TB incidence of 407/100,000/year; 52.2% of that in adults (≥ 13 
years of age). 
 
Mycobacterium bovis BCG 
BCG vaccination is recommended by the WHO for infants in TB-endemic areas as it affords 
protection against disseminated disease in children.9 However, BCG vaccination may be 
associated with local complications, such as abscess formation at the vaccination site and/or 
regional lymphadenitis. Prior to the emergence of HIV as a cause of immunosuppression, 
disseminated disease was rare (0.19–2 cases/1 million vaccinated infants) and was associated 
with congenital immunodeficiency syndromes.10  
In South Africa, a change in vaccine policy in July 2000 from percutaneous Tokyo 
strain BCG to intradermal Danish strain BCG vaccine has seen a number of adverse events 
reported in both HIV-infected and immune competent children.9, 11-12 Distant or disseminated 
disease has become a serious concern in human immunodeficiency virus (HIV)-infected  
children. In 2007 it was estimated that 417 per 100 000 HIV-infected infants, are affected by 
disseminated BCG disease,12 a rate that is about 1000 times the rate in HIV-uninfected 
infants, and with a mortality rate of 75–86%.13 
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WHO recommended in 2007 that HIV-infected infants should not receive BCG 
vaccination, 14 but this policy is very difficult to implement and may not be beneficial in 
countries where both HIV and TB are endemic, as the HIV status of the baby is not known at 
the time of routine vaccination (at birth).   Where possible however every effort should be 
made to introduce selective BCG vaccination based on known HIV status. 13 
 
Non-tuberculous mycobacteria (NTM) 
Non-tuberculous mycobacterial infection (NTM) is due to mycobacterial organisms other than 
Mycobacterium leprae or members of the Mycobacterium tuberculosis complex 15 and differ 
from the former in their habitat, contagiousness and susceptibility to chemotherapy. 
In developed countries such as the USA, as the incidence of tuberculosis has fallen, NTM are 
more frequently isolated than those of the M. tuberculosis complex. In immune competent 
adults NTM infection presents as pulmonary disease in a patient with pre-existing chronic 
pulmonary disease,15 whilst in immune competent children the organs involved are the lymph 
nodes and the skin. These children are generally under the age of six years and are otherwise 
healthy with no constitutional symptoms.16-17 
In countries with a high prevalence of TB and HIV, localized or disseminated disease 
from non-tuberculous mycobacteria may occur, but is uncommon.18 However, a case study 
from Thailand showed that of the 153 HIV-infected children who had initiated antiretroviral 
therapy, nine developed the immune reconstitution syndrome (IRIS) due to non-tuberculous 
mycobacterial organisms.19 This highlights the need for bacteriological confirmation and 
speciation in suspected cases of mycobacterial infection. 
 
Contribution of HIV 
One of the millennium development goals of the United Nations is to reduce TB-related 
mortality to 50% of the 1990 levels. Increasingly it appears that this goal will not be achieved, 
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particularly in sub-Saharan Africa,20 due in part to HIV infection, which is a major contributor 
to the escalating TB epidemic in this region and the rest of the world.21-22  It is estimated that 
in 2007 about 420 000 new HIV infections occurred in children, predominantly in sub-
Saharan Africa, through perinatal transmission, in a population vulnerable to early contact 
with tuberculosis.23 A recent study in the Western Cape Province, South Africa, recorded a 
TB incidence of 1596 (disseminated TB 240)/100 000 in HIV-infected and 66 (disseminated 
14)/100 000 in HIV-uninfected infants.8 
Autopsy studies in sub-Saharan Africa have shown that 30 to 40% of deaths in HIV-
infected adults and up to 20% in HIV-infected children are due to TB.3  In Zambia, 3 Cote d’ 
Ivoire, 24 Malawi, 25 and South Africa, 22, 26 TB-related mortality is considerably higher in 
HIV-infected compared to HIV-uninfected children.  Despite this high disease risk 
experienced by HIV-infected children, the majority of child TB cases are still in HIV- 
uninfected children, as compared to adults relatively fewer children are HIV-infected and 
young children are highly susceptible to develop TB irrespective of their HIV status.27 When 
children are co-infected with HIV and TB however, they show more rapid progression of the 
disease  and increased morbidity and mortality.28 29 
 
The diagnostic dilemma 
Children rarely have sputum smear-positive TB. Although this reduces their risk of actively 
spreading the disease, it makes it more challenging to establish a definitive diagnosis. In 
contrast to adults where the sensitivity of sputum culture approximates 80-90%,young 
children are unable to expectorate,alternative specimens such as gastric aspirates or induced 
sputa are difficult to collect and culture yields are low (widely reported as 30-40%). 30-31  
Chest radiography is regarded as the most practical test that provides a reasonably accurate 
diagnosis of intra-thoracic TB in children with suspicious symptoms. 32  However, it has 
numerous limitations including limited availability, expertise is required to interpret child 
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radiographs,33 and it has no value in the diagnosis of extra-thoracic TB.  A recent survey 
demonstrated that 10.7% of children treated for active TB had extra-thoracic disease 
manifestations only.34  TB lymphadenitis was the most common form of extra-thoracic 
tuberculosis in these children (50%). 
Traditionally, three fasting gastric aspirates samples are collected on three consecutive 
mornings, requiring hospitalization of the child and frequently the caregiver. In developing 
countries this may create severe hardship as caregivers usually have more than one child in 
their care. Caregivers may also compromise their employment by remaining in hospital for a 
prolonged period of time. Hospitalization incurs cost and occupies beds which may be needed 
for other children.  Sputum induction using mobilization and hypertonic saline have shown 
improved yield compared to gastric aspirates,30 but more recent studies demonstrated 
equivalence with gastric aspirates.35 The technique requires specialized training and 
equipment and may present a nosocomial transmission risk.27, 32, 36  
Novel culture methods have been developed in an attempt to circumvent the slow 
turnaround times, poor sensitivity and cost of conventional automated liquid broth systems. 
The most feasible alternative to date has been the microscopic observation drug susceptibility 
assay (MODS) that uses an inverted light microscope to rapidly detect “spindle and cord 
formation” in selective broth culture that is indicative of mycobacterial growth.32  Phage 
amplification assays that use bacteriophages to detect the presence of live M. tuberculosis 
have been less successful. 27   
There is abundant literature utilizing commercial and in-house PCR for the diagnosis 
of mycobacterial infection in sputum and body fluids, such as cerebral spinal fluid, but results 
in the literature are highly variable and have not been well validated in children. 27 Recent 
reviews and meta-analyses of PCR in TB meningitis, pleuritis and sputum smear-negative 
pulmonary TB demonstrated poor  sensitivity.37 In patients with sputum smear-positive TB, 
however, PCR may play an invaluable role in offering rapid species identification and 
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detection of drug resistance.32  The application in patients with sputum smear-negative or 
extra-pulmonary TB requires further evaluation and use in low income countries remains 
limited due to cost constraints.. 
T-cell assays that measure interferon- γ released by lymphocytes in peripheral blood 
after exposure to M. tuberculosis specific antigens, have been hailed as reliable TB tests; two 
commercial tests are available T-SPOT.TB and QuantiFERON –TB GOLD. However, study 
results are highly variable and the experience in children remains limited.  Current consensus 
is that these tests are unable distinguish latent infection (a third of the world population is 
latently infected) from active disease and adds little to the traditional tuberculin skin test 
(TST).  Tests are also too expensive and complex for routine use in low- income countries.27, 
32, 36, 38 
 
Fine Needle Aspiration Biopsy (FNAB) 
History  
FNAB  has been used since the early 20th century to diagnose infectious and neoplastic 
disease.39 Prior to the 1930s there were isolated case reports documenting its history, and the 
first large scale report on needle aspiration biopsies was published from Memorial Hospital, 
New York in 1930.40 In the 1960s this technique was championed by the Scandinavians and 
was widely practiced, with many publications on its utility, mainly in the Scandinavian 
literature.41  Gradually the use of FNAB spread through Europe and interest was rekindled in 
the United States in the 1980’s. FNAB is now widely utilized as a first line diagnostic 
procedure in the diagnosis of palpable masses, including peripheral lymphadenopathy. Its 
value in the diagnosis of mycobacterial lymphadenitis in adults is well documented.42-44 
FNAB is utilized throughout the developed and developing world, although the indications 
differ in these two groups. In a review of MEDLINE by Das from 1966 to 2002, 39 849 
journals published 5609 articles on FNAB, the number increasing sharply from the 1980s 
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onwards. Of the developed or high income countries, 52.8% (28/53) published articles 
compared to 29.7% (46/155) of the low income or developing economies. South Africa was 
one of the top 10 countries in the developing world with publications on FNAB. Although the 
developed countries publish significantly more articles than the developing countries, these 
tend to concentrate on breast and pancreatic disease, while the developing countries publish 
significantly more articles on small round cell tumors and infectious diseases. This may 
reflect the health care priorities and diagnostic needs of these developing countries. 
Children with pulmonary TB have extra-thoracic disease manifestations in 10 to 30% 
of cases. 45 2  TB lymphadenitis is the most common form of extra-thoracic TB in endemic 
areas, 46 where up to 50% of extra-thoracic disease manifests as  peripheral lymphadenopathy.  
In fact, TB lymphadenitis is the most common (22-48%) cause of persistent cervical 
lymphadenopathy in TB endemic areas.47-50 This is rarely recognized as a potential means for 
specimen collection. Therefore it is important to develop methods that will provide a rapid 
and definitive mycobacterial diagnosis in children with persistent cervical lymphadenopathy. 
In these high burden TB endemic areas, where children may contribute up to 40% of the TB 
caseload, 51 and assuming a conservative estimate of 5-10% of children with TB have 
peripheral lymphadenopathy, FNAB could make a significant contribution to the diagnosis of 
TB and other mycobacterial infections.   
A recent retrospective study comparing FNAB to gastric aspirates and induced sputum in 
children with pulmonary TB and peripheral lymphadenopathy showed FNAB to have a 
superior diagnostic yield and a significantly reduced time to diagnosis. 52 An accurate 
bacteriological diagnosis was made within 3 days in the vast majority of patients, which has 
important benefits for patient management. FNAB should be regarded as a first line 
diagnostic modality in paediatric TB suspects with peripheral lymphadenopathy. 
TB and HIV have many features in common which contribute to diagnostic 
difficulties, particularly in children. In this population both are chronic diseases that 
15
commonly present with pulmonary symptoms/signs and/or lymphadenopathy.53  Persistent 
peripheral lymphadenopathy is itself a criterion for the classification of HIV related disease in 
children.54 Radiological features may be impossible to interpret with certainty and in children 
with CD4 T-cell depletion, alternative tests such as the TST and or novel T-cell assays offer 
little diagnostic assistance due to poor sensitivity.55 
A study from South Africa demonstrated that the majority of HIV-infected children 
with persistent lung disease have persistent peripheral lymphadenopathy (PPL) and PPL was 
present in many children with pulmonary TB.56 In HIV-infected children, peripheral 
lymphadenopathy may be associated with many pathological entities, from infections to 
neoplasia. 56  Thus, enlarged peripheral lymph nodes were identified as important specimen 
collection sites to consider, in establishing a definitive diagnosis of TB in HIV-infected 
children.  Another important disease presentation results from the immune reconstitution 
inflammatory syndrome (IRIS), which may exacerbate the symptoms and signs of 
mycobacterial disease and needs to be distinguished from TB treatment failure. 57 55  BCG-
related right sided axillary adenitis is the most common IRIS manifestation in BCG-
vaccinated infants recently started on highly active anti-retroviral therapy (HAART).  
 
FNAB in children 
FNAB has been less widely utilized in pediatrics as a diagnostic modality, although the 
literature demonstrates a steady increase in the use of FNAB in children, achieving sensitivity 
and specificity rates of over 90% in these studies. 58-60  The majority of the studies were in 
pediatric oncology patients, where they play a role in triage, as childhood malignancy can be 
difficult to diagnose, with signs and symptoms which often mimic other common paediatric 
conditions especially viral infections. With significant mass lesions, FNAB proved to be the 
diagnostic tool of choice in the triage of these patients.61 However, in developing countries 
with a high burden of infectious diseases such as TB and HIV, FNAB can be of inestimable 
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value in confirming the diagnosis of mycobacterial infection, permitting early appropriate 
therapy, as well as a means to obtain specimens for culture, bacterial species determination 
and sensitivity testing. 60, 62-64 
FNAB is a simple and minimally invasive technique, performed at the bedside, and is 
well tolerated by children. Table 1 provides a summary of the equipment required and how to 
perform the technique.  Children under the age of six years are given are oral or intranasal 
sedation for amnesia, but children older than six years tolerate aspiration with no sedation. 
The technique is explained to the child, the caregiver is asked to remain with the child during 
the procedure and the permission of the child is requested to proceed. If the child understands 
that this is a very quick minimally painful procedure that will enable them to return home 
after a short period of observation, they are willing to cooperate.  
 
Most aspirates in children are from axillary or cervical lymph nodes that are easily accessible. 
If the procedures are performed correctly, with a small gauge needle (22-23 G or smaller) 
complications such as a small hematoma are rare. If the correct technique is utilized the yield 
as well as the acceptance of the procedure by the patients will be excellent and nursing sisters 
can be taught this technique with excellent results. In developing countries where TB is 
endemic and specimens for bacteriological diagnosis are difficult if not impossible to obtain 
from children, FNAB provides the means for accurate diagnosis in a significant percentage of 
children with mycobacterial infection.  This is particularly important in countries with a high 
HIV rate, as well as increasing rates of multi drug-resistant (MDR) and extensively drug-
resistant (XDR) TB. 
FNAB is a cost-effective diagnostic modality that may be performed at the bedside as 
an outpatient procedure.62 It requires no infrastructure or sterile environment and no 
sophisticated or expensive equipment. Superficial aspirates may be performed by clinicians, 
pathologists or trained nursing personnel and do not require local or general anesthesia.61 
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FNAB is defined as an aspirate done using a cutting needle no larger than 22G.65  This 
ensures minimal complications, the commonest of which is a small hematoma and thus FNAB 
is the safest method of obtaining a tissue diagnosis.  
A number of different techniques have been used to obtain a tissue and/or 
bacteriological confirmation of TB lymphadenitis. These include core needle biopsy,66 wide 
needle aspiration biopsy 66-67 and surgical lymph node biopsy.50, 56 None are as simple, safe 
and cost effective to perform, as FNAB (Table 2).  Compared to core needle biopsy, the risk 
of sinus or fistula formation, permanent damage to nerves or seeding of tumor along the 
needle track is minimal. 65 It permits sampling of the entire mass (node) as multiple 
excursions of the needle are performed in the lesion without withdrawing the needle, and is no 
more painful than venepuncture. No more than one ml of suction is applied during the 
aspiration as the cutting needle will ensure material enters the needle by capillary action, 
while more suction would increase the risk of bleeding and hematoma formation.    
Most aspirates yield a very small amount of material which is expressed onto a glass 
slide and a monolayer smear prepared. Preparation and staining of the smears can be done in a 
very basic laboratory using manual methods. Although screening and reporting of the 
aspirates should be performed by a cytopathologist. The smears are robust and may be 
transported or even couriered to a central laboratory service for diagnosis and reporting.  
FNAB is an effective and safe modality for obtaining a representative sample of material from 
a lymph node, but laboratory confirmation of mycobacterial adenitis can be made utilising a 
number of different investigations.  
 
Laboratory analysis 
Cytomorphology 
Cytomorphology is simple, but not specific, as other opportunistic infections may present 
with similar cytological changes and the quality of the smear is operator dependent. 42-43 A 
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number of reactions have been described in the literature: epithelioid granulomas without 
necrosis, epithelioid granulomas with necrosis and necrosis without granuloma formation. 68 
 
Ziehl-Neelson (ZN) staining 
ZN staining, even in good laboratories, is insensitive, identifying organisms in only about 
20% of culture positive samples. 44 Identification of the mycobacterial organism may be 
dependent on the immune status of the patient and is reflected in the cytomorphological 
pattern. Smears with poor granuloma formation are more likely to be positive on Ziehl-
Neelsen staining than those showing good epithelioid granulomas without necrosis. 68  
 
Autofluorescence 
Autofluorescence of mycobacteria is simple, sensitive and inexpensive, but is not widely 
used.  It is not highly specific, as the specificity is dependent on the experience of the operator 
and it cannot differentiate between the various mycobacteria. 62, 69 The recent development of 
light-emitting diode (LED) technology provides a cheap and reliable light source with a 
usable life of more than 50,000 hrs using a fraction of the energy required by conventional 
light bulbs and can run on batteries or inexpensive low-voltage power supplies. Preliminary 
studies have indicated that LED-fluorescence microscopy offers a valid alternative to 
conventional fluorescence microscopy 70 and studies are underway to investigate the 
diagnostic utility of LED-auto fluorescence microscopy to detect Mycobacteria in fine needle 
aspiration samples.  
 
Culture  
Direct inoculation into MGIT or Bactec tubes (Becton Dickinson, USA) at the bedside gives a 
high yield, 62 but it takes 1-6 weeks for a result, and  fails to differentiate the various 
mycobacteria.  Additional PCR-based testing is required for accurate speciation..  Direct 
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inoculation however is not feasible as the MGIT and Bactec collection media are expensive, 
and are not readily available in clinics and wards for use by clinicians.  We have developed an 
inexpensive transport bottle which is easy to prepare “in house” and does not require 
refrigeration.71 The positive culture yield and the time to positive culture from the transport 
medium, even after 7 days at room temperature, is statistically no different to direct bedside 
inoculation. The production and distribution of these bottles to clinics and hospitals, will 
increase the feasibility of diagnosing tuberculosis at primary health care level 
 
Nucleic acid amplification tests (NAATs) 
A small number of recent studies have shown considerable promise in the use of NAATs in 
the diagnosis of M. tuberculosis on FNAB specimens. 72-75  These studies have been 
predominantly in adults. There is limited data on the use of FNAB for the diagnosis of 
mycobacterial disease in children. Rapid and minimally invasive techniques such as FNAB, 
which can be performed on an outpatient basis, in a primary health care setting, when 
combined with a rapid and sensitive diagnostic  technique such as PCR, may substantially 
contribute to the effective management of mycobacterial infection in HIV-infected and 
uninfected children.  The implications of a rapid and accurate diagnosis include expediting 
access to appropriate and adequate therapy as well as potentially limiting further costly 
investigation. 
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Conclusion 
It is difficult to understand why such an effective, simple and safe diagnostic modality is so 
underutilized in the diagnostic workup of pediatric tuberculosis. It is ideally suited for 
widespread use in resource limited countries which carry the dual burden of TB and HIV. 
FNAB may be perceived as a procedure to be carried out by specialized medical personnel, 
but it can safely be carried out by junior medical staff and nursing staff, capable of and trusted 
with inserting intravenous lines. It has been demonstrated that samples collected by nurse 
aspirators trained during a Burkitt’s lymphoma study conducted in Malawi is of similar 
quality as those obtained by trained pathologists.  
Adequate training is essential to develop confidence in the technique and to ensure a 
good yield.56   This can be done through initial outreach teaching and training programs, 
followed by cascade training to facilitate widespread dissemination of FNAB skills.  
Pathology departments from South Africa and organizations such as the British Division of 
the International Academy of Pathology and the Friends of Africa through the United States 
and Canadian Academy of Pathology (USCAP) offer ongoing education in FNAB and 
pathology in African and other TB-endemic countries.  Most training programs incorporate 
tuition in the cytopathological diagnosis of mycobacterial infection by pathologists, as the 
advent of HIV has changed the cytomorphological appearance of these infections.   
In addition to making a rapid and definitive tissue diagnosis, widespread use of FNAB 
would provide ready access to material ideally suited to develop alternative methods for rapid 
detection of mycobacteria, species determination and drug resistance testing. In order to 
reduce the massive TB disease burden suffered by children in endemic areas we have to 
utilize creative and effective means to ensure rapid and accurate diagnosis, such as FNAB, 
that would facilitate early and appropriate treatment.   
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Table 1 
Summary of the Fine Needle Aspiration Biopsy Technique 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equipment 
22 or 23G cutting needles 
10ml disposable plastic syringes 
Glass cytology slides (ground edges) 
Commercial spray fixative or 95% alcohol 
Non Sterile gloves 
Alcohol swabs 
 
Procedure 
Clean skin, immobilize the mass, position needle to access entire mass and avoid 
passing through muscles such as sternocleidomastoid 
Insert needle firmly and apply no more than 1ml suction, applying constant suction 
throughout aspirate 
Aspirate moving the needle in a fan like fashion through the mass.  
When material is in the hub of the needle, release suction and withdraw needle. 
Ask parent or assistant to apply pressure to puncture wound 
 
Preparation of smears 
Remove needle from syringe, pull 10 ml of air into syringe and reattach needle. 
This air is used to express the material in needle onto a glass slide. Place second glass 
slide face down on first, allow material to spread gently, and keeping both slides 
together, pull gently apart. 
Fix one slide with alcohol and allow the second to air dry 
 
Culture 
If liquid culture or transport medium is available, withdraw an aliquot of liquid media 
into the syringe and then expel it back into the tube or bottle, thereby using the culture 
media to rinse the syringe and needle in a sterile fashion.  
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Table 2 
Comparison of different superficial mass lesion sample collection methods to achieve a 
definitive tissue diagnosis  
 
 Open surgical 
biopsy 
Core needle 
biopsy 
Standard Needle 
Aspiration  
(greater than 
22G) 
Fine Needle 
Aspiration 
Biopsy  
(22G or smaller) 
Suitable for 
small lesions 
(1x1cm) 
Yes No Yes Yes 
Entire mass 
sampled 
Yes, if excision No No Yes 
Complications Risk of 
anaesthesia, 
hospitalization, 
sinus 
formation, 
infection 
Sinus 
formation, 
infection 
Rare Extremely rare 
Cost Hospitalization, 
theatre time 
High cost of 
needle  
Minimal Minimal 
Hospitalisation Yes No No No 
Anaesthetic 
required 
General Local Local None 
Time for entire 
procedure 
1-2 days 30 minutes 30 minutes 10 minutes 
Tissue diagnosis Yes Yes Yes Yes 
Microscopy for 
organism 
Yes Yes  Yes Yes 
Culture Yes  Yes Yes Yes 
Time for initial 
result 
1-2 days 1-2 days 12-24 hours   
(Possible in <1 
hr) 
12-24 hours   
(Possible in <1hr) 
 
 
31
Table 3 
Comparison of methods to confirm a mycobacterial diagnosis in children 
 
Method Hospitalization 
required 
Suitable  
ages 
Local/general 
anaesthetic 
Equipment / 
infrastructure 
FNAB No All No None 
Gastric 
aspirates 
Yes All No None 
Induced 
sputum 
Yes All No Nebulizer, suction, 
saturation monitor 
Sputum No >7-8yrs only No None 
Surgical 
biopsy 
Yes All Yes Full theatre 
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ORIGINAL STUDIES
Tuberculous Lymphadenitis as a Cause of Persistent
Cervical Lymphadenopathy in Children From a
Tuberculosis-Endemic Area
Ben J. Marais, MRCP (Paed), FCP (Paed), MMed,* Colleen A. Wright, MMed, FCPath, FRCPath, FIAC,†
H. Simon Schaaf, MMed, MD (Paed),* Robert P. Gie, FCP (Paed),* Anneke C. Hesseling, MBChB, MSc,*
Don A. Enarson, MD,‡ and Nulda Beyers, FCP (Paed), MSc, PhD*
Background: Cervical lymphadenitis is the most common form of
extrapulmonary tuberculosis in children, although its relative con-
tribution as a cause of persistent cervical adenopathy is not well-
documented. The aim of this study was to determine the relative
contribution of tuberculous lymphadenitis as a cause of persistent
cervical adenopathy in a tuberculosis-endemic setting and to docu-
ment its clinical presentation at the primary health care level.
Methods: A prospective descriptive study was conducted from
February 2003 through October 200 at 5 primary health care clinics
in Cape Town, South Africa. The study included all children
younger than 13 years presenting with persistent cervical adenopa-
thy to the local primary health care clinic.
Results: A total of 158 children were evaluated of whom 35 (22.2%)
were diagnosed with tuberculous lymphadenitis. Bacteriologic con-
firmation was achieved in 27 of 35 (77.1%) children; all 35 re-
sponded to standard antituberculosis treatment. The majority of
those without tuberculous lymphadenitis (105 of 123, 85.4%) had a
visible superficial lesion in the area drained by the affected nodes. In
children with persistent lymphadenopathy 2  2 cm, tuberculosis
lymphadenitis was diagnosed in 31 of 33 (93.9%); specificity was
98.4%, sensitivity was 88.6% and the positive predictive value was
93.4%.
Conclusion: Children commonly present with persistent cervical
adenopathy to the primary health care clinic. The use of a simple
clinical algorithm provided an accurate diagnosis of tuberculous
lymphadenitis in the study setting. Fine needle aspirations provided
a rapid and definitive diagnosis in the majority of children and will
have added diagnostic value in settings where alternative diagnoses
are more likely.
Key Words: tuberculosis, lymphadenitis, children, persistent
cervical adenopathy
(Pediatr Infect Dis J 2006;25: 142–146)
Peripheral tuberculous lymphadenitis predominantly in-volves the cervical lymph nodes1–5 and is the most com-
mon form of extrapulmonary tuberculosis in children from
tuberculosis-endemic areas.1,2 However, its relative contribu-
tion as a cause of persistent cervical adenopathy in these
communities is not well-documented.
Cervical lymphadenitis, caused by Mycobacterium tu-
berculosis, is generally considered to have its origin in the
lymphatic spread of organisms from a primary pulmonary
focus, but in a minority of cases it can originate from a
primary focus in the mouth, tonsils, oropharynx or tissues of
the head and neck.6 Other mycobacteria can also cause
cervical lymphadenitis; the relative contribution of different
mycobacteria is influenced by the control of bovine tubercu-
losis,7 the use of BCG vaccination,8 the presence of environ-
mental mycobacteria and the prevalence of tuberculosis
within a particular setting.7
The diagnosis of tuberculosis in children is often dif-
ficult, given that symptoms and signs might be nonspecific,
the collection of bacteriologic specimens problematic and
bacteriologic yields low.9,10 In children with peripheral tu-
berculous lymphadenitis, however, clinical signs are usually
apparent, and fine needle aspiration (FNA) provides excellent
bacteriologic yields.11–13 Although the diagnostic value of
FNA has been demonstrated in resource-limited settings,11–13
to date it remains underutilized as a routine diagnostic mo-
dality in most endemic areas.
The aim of this study was to determine the relative
contribution of tuberculous lymphadenitis as a cause of per-
sistent cervical adenopathy in children from a tuberculosis-
endemic area and to document its clinical presentation at the
primary health care level.
METHODS
A prospective descriptive study was performed from
February 2003 through October 2004 in Cape Town, the
Western Cape Province, South Africa.
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Setting. The study was conducted at 5 primary health care
clinics served by one referral hospital. The incidence of all
tuberculosis in Cape Town was 678/100,000,14 and the preva-
lence of human immunodeficiency virus (HIV) infection among
women attending public antenatal clinics in the Western Cape
Province was 13.1% (95% confidence interval, 8.5–17.7%), in
2003.15 Bovine tuberculosis is well-controlled within the study
communities, and children receive routine neonatal Calmette-
Gue´rin bacillus (BCG) vaccination. The study communities
rarely use private medical services, and children diagnosed with
tuberculosis are routinely referred to the local primary health
care clinic, where supervised antituberculosis treatment is pro-
vided free of charge. Pediatric services are extended only to
children younger than 13 years of age.
Study Population. All children (younger than 13 years of age)
who presented with persistent cervical adenopathy; defined as
lymph nodes 1  1 cm, persisting for 4 weeks despite a
course of oral antibiotics (usually amoxicillin), were referred
to the investigator for evaluation.
Data Collection and Surveillance. The principal investigator
visited each clinic on a weekly basis to screen referred
children, whereas a study nurse recorded children referred
directly to hospital. The areas surrounding the affected cer-
vical lymph nodes were inspected to exclude a visible super-
ficial lesion within their drainage area (visible local cause),
such as impetigo of the scalp, tinea capitis or traction follic-
ulitis. Those with a visible local cause were given appropriate
therapy and instructed to return if the lymph nodes persisted
or increased in size. Surveillance was continued at all 5
clinics and the referral hospital throughout the study period,
and for an additional 3 months after enrollment was stopped,
to document any child who subsequently returned with symp-
tom deterioration or a possible diagnosis of tuberculosis.
Children with no visible local cause of cervical lymph-
adenopathy received a Mantoux (2 tuberculin units of purified
protein derivative RT23 intradermal) tuberculin skin test
(TST) and a chest radiograph (anteroposterior and lateral).
The Mantoux TST was interpreted as positive if induration
was 10 mm. Two independent experts evaluated the chest
radiographs for intrathoracic signs of tuberculosis. Symptoms
and signs as well as possible tuberculosis contact were
documented. Children diagnosed with tuberculous lymphad-
enitis were offered a rapid HIV test (Determine HIV 1/2;
Abbott) after appropriate counseling. Standard 3-drug antitu-
berculosis treatment was initiated,16 and response to antitu-
berculosis therapy was monitored after a period of 3 months.
In the group not diagnosed with tuberculous lymphadenitis,
symptom resolution in the absence of antituberculosis therapy
was monitored.
Case Definition. Tuberculous lymphadenitis was defined as
cervical lymphadenopathy 1  1 cm persisting for 4
weeks despite a course of oral antibiotics, in the presence of
at least 1 of the following criteria: (1) bacteriologic confir-
mation: isolation of M. tuberculosis from a lymph node, or
microscopically visible acid-fast or autofluorescent bacilli
associated with amorphous necrosis on cytology; or (2) clin-
ical diagnosis: significant therapeutic response (lymph node
size decreased from2 2 cm to1 1 cm after 3 months
of standard antituberculosis treatment). All cultures positive
for M. tuberculosis complex were routinely speciated by
polymerase chain reaction to differentiate M. tuberculosis
from Mycobacterium bovis and M. bovis BCG.17
FNA and/or Biopsy. Of the children enrolled, only those with
a positive TST (10 mm) and/or a suggestive chest radio-
graph and/or a cervical mass 2  2 cm were referred to the
hospital for FNA. FNA was performed in the pediatric out-
patient department with sedation and pain relief (chloral
hydrate 20–50 mg/kg and paracetamol 10–20 mg/kg, admin-
istered orally 30–60 minutes before the procedure). The
largest discrete node was identified by careful palpation of the
cervical mass. Two needle passes were performed with a
23-gauge needle attached to a 10-mL syringe, applying 2 mL
of suction. Aspirated material was placed on standard micro-
scope slides, thinly smeared and air-dried or fixed with
commercial spray fixative for Giemsa and Papanicolou stains,
before flushing the syringe and needle directly into a MGIT
(Becton Dickinson, Cockeysville, MD) mycobacterial culture
bottle. Microscopic evaluation included cytology, acid-fast
staining and autofluorescence.18 Excision biopsies were oc-
casionally performed if children presented with persistent
cervical adenopathy to the referral hospital without a letter
from the investigator or if the FNA was inconclusive.
Statistical Analysis. Descriptive analysis was conducted with
SPSS (version 11.5). The sensitivity and specificity of a
simple clinical algorithm were calculated with the use of
either bacteriologic confirmation and/or the clinical case
definition (see case definition) as the “reference” test.
Parents gave written informed consent for study partic-
ipation and ethics approval was obtained from the Institu-
tional Review Board of Stellenbosch University, the City of
Cape Town Health Department and local health committees.
RESULTS
Persistent Cervical Adenopathy. Of the 167 children who
were identified with persistent cervical adenopathy, 9 (5.4%)
did not return to the clinic for evaluation by the investigator
(Fig. 1). Of the 158 children evaluated, 53 had no visible
cause of whom 40, with either a positive TST or a cervical
mass 2  2 cm, were referred to hospital to establish a
histologic diagnosis. None of the 13 TST-negative children
had radiographic or other clinical signs indicative of possible
tuberculosis, and all children judged not to have tuberculosis
on clinical grounds showed symptom resolution in the ab-
sence of antituberculosis treatment.
Table 1 summarizes the demographics and etiology of
persistent cervical adenopathy in the 158 children who were
evaluated. The majority of children (105, 66.5%) had lymph
nodes 2  2 cm with a visible local cause; 28 returned for
reevaluation within 1 month; the lymphadenopathy resolved
in 18 and decreased to 1  1 cm in 9. Multiple discrete
lymph nodes, 1–2 cm in diameter, remained in 1 child who
was TST-negative and asymptomatic. The lymphadenopathy
showed slow resolution, decreasing to 1  1 cm within 3
months. None of the children with a visible local cause
returned to the clinic with symptom deterioration or with a
possible tuberculosis diagnosis from any hospital, during the
study period.
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Of the 53 (33.5%) children without a visible local cause,
tuberculous lymphadenitis was diagnosed in 35 (66.0%). Of
those with a cervical mass 2  2 cm, tuberculous lymphade-
nitis was diagnosed in 31 of 33 (93.9%). Of the 2 remaining
children, 1 had an unidentified chronic inflammatory process
diagnosed through excision biopsy, and the other developed a
chronic bacterial abscess after repeat courses of oral antibiotics,
requiring eventual incision and drainage. Two children pre-
sented with acute bacterial adenitis; both had a history of
persistent lymph node enlargement that preceded the acute
event. Both these children were TST-positive and were
diagnosed with secondary bacterial infection, as M. tuber-
culosis was cultured after incision and drainage. One had
signs suggestive of tuberculosis on the chest radiograph
and reported a prolonged cough and night sweats, whereas
the other had no additional suspect symptoms or signs
apart from the cervical mass and a positive TST.
Tuberculous Lymphadenitis. Of the 35 children diagnosed with
tuberculous lymphadenitis (Fig. 1), bacteriologic confirmation
was achieved in 27 (77.1%) children. Of the 8 children without
bacteriologic confirmation, 7 failed to attend the referral hos-
pital, and 1 refused permission for FNA. All 8 had a TST
response15 mm and showed excellent response to standard
antituberculosis treatment. In the 27 children with bacterio-
logic confirmation; FNA was performed in 21 children and
formal biopsies in 6. No cases caused by M. bovis, M. bovis
BCG, infection with environmental mycobateria such as
Mycobacterium avium-intracellulare complex or Mycobacte-
rium scrofulaceum or malignancies were identified.
Of the 21 children with tuberculous lymphadenitis in
whom FNA was performed, 16 of 21 (76.2%) were acid-fast
or autofluorescent smear-positive, which allowed rapid and
definitive diagnosis. Culture confirmation was achieved in 19
of 21 (90.5%), of whom 2 had no microscopic features
indicative of tuberculosis. One of the 2 children who were
culture-negative had received antituberculosis treatment be-
fore FNA was performed. Either a positive culture or typical
microscopic features were present in all 21 cases. One of the
2 children, who had no microscopic features indicative of
tuberculosis on FNA, had an excision biopsy performed that
established the diagnosis, before the FNA culture result
became known. No immediate complications relating to the
FNA procedure, apart from minimal bleeding, were noted.
No long term complications, such as sinus formation, were
recorded during the 3-month follow-up period.
Table 2 reflects the lymph node characteristics and
associated findings in the 35 children diagnosed with tuber-
culous lymphadenitis. Using the clinical algorithm of a per-
sistent cervical mass 2  2 cm, without a visible local
cause or response to antibiotics, accurately identified children
with tuberculous lymphadenitis; sensitivity was 88.6%, spec-
ificity was 98.4% and the positive predictive value of this
clinical algorithm was 93.4%.
Tuberculous lymphadenitis occurred in children of all
ages, except in infants. In 18 (51.4%), lymph nodes occurred
in the anterior triangle, with involvement of multiple regions
in 5 (14.3%). Other regions involved were: posterior triangle,
8 (22.9%); submandibular, 2 (5.7%); and supraclavicular, 2
(5.7%). Lymph nodes occurred more regularly on the right
TABLE 1. Demographics and Etiology of Persistent
Cervical Adenopathy in Children (n  158)
No. of Instances
Demographics
Gender
Male 69 (43.7)*
Female 89 (56.3)
Age groups
5 yr 93 (58.9)
5–9 yr 51 (32.2)
10 yr 14 (8.9)
Etiology
Visible local cause 105 (66.5)
Bacterial infection (crusted impetigo) 26 (16.5)
Tinea capitis (with secondary infection) 34 (21.5)
Traction folliculitis 44 (27.8)
Otitis externa 1 (0.6)
No visible local cause 53 (33.5)
Tuberculous lymphadenitis 35 (22.2)
Reactive nodes† 13 (8.2)
Nonspecific inflammation 4 (2.5)
Nonacute bacterial abscess 1 (0.6)
Malignancy 0
*Numbers in parentheses, percent.
†Cervical mass 2  2 cm, tuberculin skin test-negative and natural symptom
resolution.
FIGURE 1. Flow diagram of children referred with persistent cer-
vical adenopathy. Not TB indicates symptom resolution in the
absence of antituberculosis chemotherapy. TB, bacteriologic con-
firmation: isolation ofM. tuberculosis from a lymph node, or mi-
croscopically visible acid-fast or autofluorescent bacilli associated
with caseating necrosis on cytology or clinical diagnosis; significant
therapeutic response (lymph node size decreased from 2  2
cm to 1  1 cm after 3 months of standard antituberculosis
treatment); Not evaluated, did not return to the clinic for evalua-
tion by the investigator; Rx response, clinical diagnosis together
with significant therapeutic response in the absence of FNA or
biopsy-based diagnosis; classified as not TB: 1 chronic inflamma-
tory process diagnosed after excision, 1 nonacute bacterial abscess
diagnosed after incision and drainage.
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side: right, 19 (54.3%); left, 13 (37.1%); bilateral, 3 (8.6%).
Most lymph nodes were multiple, either discreet or matted
(30, 85.7%), either discreet or matted, and solid (28, 80.0%).
All lymph nodes were nontender, either discreet or matted,
except 2 with secondary bacterial infection. A sinus devel-
oped in 2 children, one before presentation and the other after
surgical incision and drainage.
Associated findings in children with tuberculous lymph-
adenitis included a positive TST in 33 of 35 (94.3%). Two
(5.7%) children had a nonreactive TST; 1 was HIV-infected,
the other was severely ill with coexistent pulmonary tuber-
culosis. The TST in the latter patient measured 16 mm when
repeated after 3 months of antituberculosis treatment. Twen-
ty-nine (82.9%) children were tested for HIV, and 1 (3.5%)
was HIV-infected. Contact with an adult index case was
reported in 19 (54.3%), whereas in a further 2 cases, adults
with suspicious symptoms were subsequently diagnosed with
tuberculosis. Constitutional symptoms were present in 21
(60.0%) children, and the chest radiograph was suggestive of
primary pulmonary tuberculosis in 13 (37.1%).
The response to standard antituberculosis therapy was
good, and most children showed considerable improvement,
with reduction in lymph node size to 1  1 cm after 3
months of standard antituberculosis treatment. Three (8.6%)
children deteriorated initially; 1 developed upper airway
obstruction that required surgical lymph node enucleation and
the addition of corticosteroids. All 3 children showed good
response after completing 6 months of standard antitubercu-
losis therapy, although a cervical mass of 1  1 cm re-
mained in 1 child.
DISCUSSION
Children commonly presented with persistent cervical
adenopathy to primary health care clinics in the study setting.
The majority of these children had visible local lesions such
as crusted impetigo, infected tinea capitis or traction follicu-
litis. The hair of most small girls in this community is tightly
braided, which often leads to irritation and bacterial infection
of the hair follicles. This also explains the overrepresenta-
tion of girls in the study population. It is understandable that
none of these conditions responded to a short course of oral
antibiotics, in the absence of etiology-specific systemic
and/or local treatment.
A simple clinical algorithm that identified children with
persistent (4 weeks) cervical lymphadenopathy, no visible
local cause or response to antibiotics and a cervical mass
2  2 cm showed excellent diagnostic accuracy within the
study setting. The addition of a positive TST may be of value
in settings where infection with M. tuberculosis is less com-
mon or where conditions other than tuberculosis, such as
malignant lymph node involvement or other chronic infec-
tions, are more common and may present with a similar
clinical picture. The fact that accurate clinical diagnosis is
possible at the primary health care level might allow the
initiation of antituberculosis treatment without hospital refer-
ral, which should improve access to care for children in
extremely resource-limited settings. However, regular fol-
low-up (at least monthly) is essential so that children who
do not respond to standard antituberculosis treatment are
referred as soon as possible to establish a definitive diag-
nosis. The value of this clinical approach requires further
evaluation.
FNA proved to be a robust and simple technique, which
provided an excellent bacteriologic yield. No significant side
effects were noted. FNA provided a definitive bacteriologic
diagnosis with the ability to speciate M. tuberculosis complex
and to perform drug susceptibility testing. A definitive diag-
nosis is always desirable, but the diagnostic value of FNA
will be even greater in settings where a clinical diagnosis is
expected to be less accurate, such as areas where malignant
lymph node involvement and/or other chronic infections are
more common.11,12
The lymph node characteristics and constitutional symp-
toms recorded in this study correlate well with findings from
Papua New Guinea and India.3,4,19 The most distinctive fea-
tures were the chronic persistent course, the lymph node size
(2  2 cm) and the involvement of multiple, discrete or
matted, lymph nodes. The study also emphasizes the value of
TABLE 2. Clinical Characteristics of Children With
Tuberculous Lymphadenitis (n  35)
No. of Instances
Lymph node characteristics
Persistence (present for 4 wk, no response to
antibiotics)
35 (100)*
Size†
2  2 cm 4 (11.4)
(2–4)  (2–4) cm 25 (71.5)
4  4 cm 6 (17.1)
Character
Single 5 (14.3)
Multiple
Discreet 14 (40.0)
Matted 16 (45.7)
Solid 28 (80.0)
Fluctuant
Without secondary bacterial infection 5 (14.3)
With secondary bacterial infection (red
and warm)
2 (5.7)
Associated findings
Tuberculin skin test
0 mm 2 (5.7)
1–9 mm 0
10 mm 33 (94.3)
15 mm 32 (91.4)
Mean response 19.1 mm (standard deviation
2.9 mm)
Constitutional symptoms
Any symptom 21 (60.0)
Fever 7 (20.0)
Cough 9 (25.7)
Night sweats 8 (22.8)
Fatigue‡ 19 (54.3)
Failure to thrive§ 10 (28.6)
Chest radiograph
Suggestive of tuberculosis 13 (37.1)
Lymph node disease
Uncomplicated 8 (22.8)
With airway compression 1 (2.9)
With parenchymal consolidation 4 (11.4)
*Numbers in parentheses, percent.
†Transverse diameter of the largest cervical mass.
‡Less playful and active since the mass was first noted.
§Crossing at least 1 centile line in the preceding 3 months or having lost10% of body
weight (minimum, 1 kg) over any time interval.
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clinical follow-up and serial measurement of enlarged lymph
nodes if the diagnosis is not apparent.20
Only 1 child with tuberculous lymphadenitis was HIV-
infected. This reflects the low HIV prevalence among chil-
dren in the study setting but might also illustrate a decreased
tendency in HIV-infected children to develop peripheral
tuberculous lymphadenitis, as suggested in a comparative
study from Zambia.21 FNA may have increased diagnostic
value in HIV-infected children, because the relative contri-
bution of tuberculous lymphadenitis to persistent cervical
adenopathy in this group is expected to be smaller.
It is interesting that no environmental mycobacteria
were isolated, although it is reported to be the most common
cause of persistent cervical adenopathy in the developed
world.22 Paucity of disease caused by environmental myco-
bacteria has also been described in other tuberculosis-en-
demic countries, such as India.23,24 This may result from the
protective effect afforded by routine neonatal BCG vaccina-
tion,8 whereas natural infection with M. tuberculosis might
provide additional protection against disease caused by envi-
ronmental mycobacteria.
An important study limitation is that bacteriologic confir-
mation was achieved in only 77.1% of the study patients, as it
was not attempted in 8 children. However, we are confident that
the diagnosis was accurate, given the fact that these 8 children all
had a TST response 15 mm and showed excellent clinical
response to standard antituberculosis treatment.
In conclusion, the use of a simple clinical algorithm
identified tuberculous lymphadenitis with a high degree of
accuracy in the study setting, whereas FNA provided a rapid
and definitive diagnosis in the majority of children.
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Abstract
Background: Little information is available on the value of fine needle aspiration biopsy (FNAB) in routine
paediatric practice in resource-limited settings.
Aim: To provide an overview of all paediatric FNAB samples received at Tygerberg Hospital, Cape Town, South
Africa over a 3-year period, including the determinants of sample adequacy and the diagnoses.
Methods: Samples were analysed from three locations: Tygerberg Hospital (TBH) where pathologists performed all
the procedures, surrounding clinics where aspirates were mostly performed by doctors with no formal training in
FNAB technique, and Queen Elizabeth Hospital, Blantyre, Malawi where FNABs were performed by trained nurse
aspirators.
Results:A total of 830 aspirates were reviewed: 464 (56%) from TBH, 264 (32%) from local clinics and 102 (12%)
from Blantyre. The main diagnoses at TBH were mycobacterial infection (31%), normal/reactive tissue (27%) and
malignancy (14%); malignancy dominated (74%) in the select group from Blantyre. Sample adequacy rates were
similar between pathologists and nurse aspirators [399/464 vs 82/102, odds ratio (OR) 1.4, 95% confidence
interval (CI) 0.8–2.6]. Results were significantly better in the group who received formal training (TBH and
Malawi) than in the clinics where clinicians had no formal training (481/566 vs 171/264, OR 3.1, 95% CI 2.2–
4.4).
Conclusions: FNAB provides a definitive tissue diagnosis in the majority of patients. Well-trained nurse aspirators
perform as well as pathologists, indicating the feasibility of FNAB in resource-limited settings.
Introduction
Fine needle aspiration biopsy (FNAB) has
been used as a diagnostic modality for more
than a century. It was initially applied to
infective and inflammatory lesions only, but
the advent of cytological investigation
(around 1925) expanded its diagnostic
application to confirm or exclude malig-
nancy also.1 FNAB is well established as
the diagnostic procedure of choice for
superficial mass lesions.2–4 However, few
data are available on its routine use in
paediatric practice, especially in resource-
limited settings.
FNAB provides a simple, fast, cost-
effective and safe method of obtaining a
definitive tissue diagnosis.3–7 In experienced
hands, a high level of diagnostic accuracy is
possible, averting the need for a formal
biopsy and all its associated risks.8 Apart
from providing a cytological diagnosis,
FNAB also provides tissue for ancillary
tests, such as microbiological cultures, flow
cytometry, cytogenetics, electron micro-
scopy and polymerase chain reaction
(PCR).2,5
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If the procedure is performed according
to established protocols, the disadvantages
are minimal.9 Potential complications
include pain, bleeding, infection, vasovagal
reactions, haemothorax, pneumothorax, air
embolism, seeding along the needle tract
and perforation of organs.9 As a general
rule, the rate of complications rises with use
of larger calibre needles and deep organ
aspiration. Contra-indications for FNAB are
few but include an abnormal clotting profile
(especially for deep organ aspirations) and
suspected vascular lesions, and aspiration in
the region of the thorax is best avoided in
patients with cardiovascular and/or respira-
tory dysfunction.9 The risk associated
with the aspiration of superficial masses
using small gauge needles (22G or less) is
minimal.2,9
Previously at Tygerberg Hospital, clini-
cians without formal training in the correct
technique performed routine FNAB, but
since July 2001 trained pathologists perform
all paediatric fine needle aspirates. The
study aims were to provide an overview of
all diagnoses made during the 1st 3 years of
this new policy and to investigate possible
determinants of sample adequacy.
Methods
Study population
This retrospective descriptive study
reviewed all paediatric FNAB samples
received by the cytology laboratory at
Tygerberg Hospital (TBH) from 1 July
2001 to 30 June 2004. These included
samples received from TBH and surround-
ing clinics and specimens couriered from
Queen Elizabeth Hospital, Blantyre,
Malawi. The cases referred from Malawi
were all enrolled in a paediatric oncology
study and represent a very select group.
Children were recruited into this study and
underwent FNAB if they presented with a
mass lesion suspected of being Burkitt’s
lymphoma.10
Fine needle aspiration biopsy
FNAB were usually performed in the clinic,
in the paediatric outpatient department or in
the ward. Children received sedation and
pain relief (usually chloral hydrate 20–50 mg/
kg and paracetamol 10–20 mg/kg) orally 30–
60 minutes before the procedure. Before
performing the aspiration, the largest discrete
mass was identified by careful palpation,
(usually using a 23G-needle attached to a
10-ml syringe and applying 2 ml of suction).
Aspirated material was placed on standard
microscope slides, thinly smeared and air-
dried or fixed with commercial spray fixative
for Giemsa and Papanicolaou stains. If
tuberculosis was clinically suspected, the
needle and syringe were rinsed in mycobac-
terial growth tube indicator (MGIT, Beckton
Dickinson, USA) medium for mycobacterial
culture. All mycobacterial isolates were
identified as Mycobacterium tuberculosis,
Mycobacterium bovisBCG or non-tuberculous
mycobacteria (NTM) by polymerase chain
reaction (PCR) testing.
Data collection and analysis
Cytology results were captured in a compu-
terised database. We reviewed the results of
all FNAB samples received during the 3-
year study period from patients (16 years
of age. Relevant information including
patient demographics, specimen character-
istics and final diagnosis was transferred to a
Microsoft Excel spreadsheet. Descriptive
statistical analysis was performed using
Statistica 7.
Written, informed consent to the FNAB
procedure was obtained from the parent
or legal guardian. Ethics clearance was
obtained from the institutional review board
of the University of Stellenbosch.
Results
A total of 830 aspirates were reviewed, 464
(56%) from TBH, 264 (32%) from local
66 C. A. Wright et al.
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clinics and 102 (12%) from Malawi. In
general, the age and gender distribution was
uniform (406, 51% female), but Malawi had
more males (63% male vs 37% female) and
the clinics had more females (57% female vs
43% male).
Peripheral lymph nodes were most fre-
quently aspirated (376, 45%); of the lymph
nodes specified, 70% were cervical and 30%
axillary. Aspiration sites for the remaining
454 samples were distributed as follows:
head and neck (124, 15%), chest and
abdomen (98, 12%), breast (66, 8%), site
not specified (166, 20%). All 66 breast
tissue samples were collected from pubertal
girls and came from the clinics, constituting
25% of clinic samples. In Malawi where all
the children were clinically suspected of
having Burkitt’s lymphoma, the bulk of
aspirates (44, 43%) came from the head
and neck area, 28 (27%) from the chest,
abdomen or pelvis and in 30% of cases the
site was not specified.
The cytological diagnosis was assessed in
conjunction with the clinical and radiologi-
cal findings and all clinically or cytologically
suspected lymphomas at TBH were aspi-
rated for flow cytometry. Where appropri-
ate, immunocytochemistry was performed
on neoplasms. All solid neoplasms were
managed according to SIOP (International
Society for Paediatric Oncology) protocols,
and histology was done after chemotherapy.
Where there was any uncertainty as to the
precise diagnosis after FNAB, the mass was
excised or biopsied prior to chemotherapy.
All cases of suspected mycobacterial
infection received bedside inoculation for
mycobacterial culture and subsequent
speciation.
All aspirates from Malawi were referred
after clinical assessment as Burkitt’s lym-
phoma and, when confirmed by cytology,
patients were commenced on limited che-
motherapy according to the study protocols
and response to treatment was carefully
monitored.
The most common diagnostic category
was normal/reactive tissue, followed by
mycobacterial infection and lymphoma, in
particular Burkitt’s lymphoma. However,
the distribution of diagnostic categories
showed marked variation between the dif-
ferent centres. Mycobacterial disease was
the most common diagnosis in children
from TBH and Burkitt’s lymphoma in the
select group from Malawi. Among the
children with mycobacterial infection, M.
bovis BCG was identified in 20 (22.5%)
cases. All these children had right-sided
axillary lymph node enlargement and were
,2 years of age (average age ,1 y). M.
tuberculosis was identified in 67 (75.3%)
cases, mostly from cervical lymph nodes,
and was equally prevalent in all age groups
(average age 5.7 y). In Malawi, Burkitt’s
lymphoma was seen predominantly between
the ages of 2 and 12 years (average age 6.3),
corresponding to the age of maximum
prevalence of endemic Burkitt’s lym-
phoma.11 No significant seasonal or other
time-related variation was recorded on
reviewing the temporal profile of cases with
TB or Burkitt’s lymphoma.
Of all aspirates received, 464 (56%) were
performed by pathologists (TBH), 264
(32%) by clinicians (clinics) and 102
(12%) by nurse aspirators (Malawi).
Pathologists and nurse aspirators received
formal training in FNAB technique but few
of the clinicians. Fig. 1 indicates the ade-
quacy of samples received; in total, 174
(21%) samples were regarded as inade-
quate. The proportion of inadequate sam-
ples varied widely between centres, TBH
14%, Malawi 20% and clinics 35%. This
reflects differences between the aspirator
groups, adequate samples being 86% in the
pathologist group, 80% in the nurse aspira-
tor group and 65% in the untrained clinician
group. Sample adequacy rates were similar
between pathologists and nurse aspirators
(399/464 vs 82/102; OR 1.4, 95% CI 0.8–
2.6) but were significantly better in the
group who received formal training (TBH
and Malawi) than in the clinics where
clinicians did not receive formal training
(481/566 vs 171/264, OR 3.1, 95% CI
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2.2–4.4). The sample adequacy rate also
differed according to the number of passes
performed, single pass 75% and more than
one pass 85% (85% vs 75%, OR 1.9, 95%
CI 1.3–2.8).
Discussion
FNAB is widely used as a first-line diag-
nostic procedure for the diagnosis of mass
lesions in adults, but it is used less fre-
quently in children, especially so in
resource-limited settings where it has the
greatest diagnostic potential. This study
demonstrates that FNAB is a feasible option
in resource-limited settings; well trained
nurse aspirators performed as well as trained
pathologists and the procedure can be done
on an outpatient basis.
Nurse aspirators from Malawi who
attended a short training course at TBH
and received clear operating procedure
guidelines achieved an adequacy rate of
80%, despite the fact that multiple needle
passes were restricted. The technique shown
was subsequently implemented within the
units. This was a highly select patient group
with clinically diagnosed Burkitt’s lymphoma
who were enrolled in a trial that investigated
cost-effective management of Burkitt’s lym-
phoma in resource-limited countries.10 In
the absence of a local cytopathologist, the
slides were fixed and sent to TBH for review.
This trial demonstrated that diagnostic slides
can be transported easily and safely using
standard courier services, enabling cyto-
pathologists to provide a long-distance
diagnostic service for countries without
cytopathology services.
The diagnostic value of FNAB is com-
pletely dependent on the quality of the
sample presented to the cytopathologist.
Optimal FNAB technique together with
adequate slide preparation and preservation
is taught poorly, if at all, to medical students
in South Africa. The technique is usually
acquired by observing and assisting senior
clinicians, most of whom receive no formal
training, resulting in the propagation of
incorrect techniques and a high percentage
of inadequate samples. Samples are fre-
quently bloody, inadequately spread and
poorly fixed, making it impossible for the
pathologist to interpret the smears. The
resulting non-diagnostic reports promote
the misconception that FNAB is a technique
with a poor diagnostic yield.
Before January 2001, FNAB was not
widely used by clinicians at TBH. This
was partly due to inadequate training in
FNAB technique and under-recognition of
the valuable contribution that FNAB could
make to the management of infective and
neoplastic lesions in children. Since 2001,
cytopathologists have provided the FNAB
service at TBH, and the diagnostic use and
yield of FNAB in children has increased; an
outreach programme has been established
offering short practical tutorial sessions to
FIG. 1. Adequacy rates of FNAB by aspirator: pathologists 86%, untrained clinicians 65%, nurse aspirators 80%
(& inadequate, % adequate).
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interested clinicians, combined with
follow-up of subsequent aspirates received,
providing positive feedback and constructive
advice.
The advanced training and experience of
the cytopathologists might partly explain the
excellent results achieved, although nurse
aspirators in Malawi who received training in
the correct technique achieved comparable
results. The performance of more than one
needle pass also improved sample adequacy
and diagnostic yield. In total, more than one
needle pass was performed in 40% of
patients, 59% at TBH, 18% in the clinics
and 11% in Malawi. In Malawi, multiple
needle passes were restricted in an attempt to
minimise the risk of needle tract spread, a
precaution recommended in children sus-
pected of having a malignant neoplasm.
This lack of training is not unique to
developing countries. In a study of breast
aspirates, Ljung showed that physicians
trained in FNAB technique missed signifi-
cantly fewer malignant lesions than physi-
cians who had received no training (2% vs
25%, p,0.0001).12 This was not affected by
the number of aspirates performed by
individual aspirators.
Few studies have reported on the value
and limitations of FNAB in routine paedia-
tric practice. In the USA, Wakely reported a
sensitivity and specificity rate of 97% and a
positive predictive value of 95% throughout
the entire age range of infancy and child-
hood.3 Handa showed FNAB to be an
excellent procedure for the triage of patients
with significant lesions requiring treatment
or referral to specialised services in India.8 A
paediatric oncology study in the USA
demonstrated that FNAB is an excellent
tool for the diagnosis of primary and
recurrent malignant neoplasms.6 These
results were supported by a South African
study of paediatric oncology patients where
FNAB showed a sensitivity of 96.1% and a
specificity of 100%.13
FNAB is used increasingly for the diag-
nosis of infectious disease, particularly
tuberculosis.14,15 Poor countries bear the
brunt of paediatric tuberculosis,16 necessi-
tating optimal use of limited resources. It
has been reported that cervical lymphadeni-
tis is the most common extra-thoracic
manifestation of paediatric tuberculosis in
India and South Africa,17–19 but differentia-
tion from other infections such as M. bovis
BCG, non-tuberculous mycobacteria, fun-
gal infections or malignancies such as
Burkitt’s lymphoma or Kaposi’s sarcoma is
important.20,21 FNAB is a minimally inva-
sive procedure that offers a definitive tissue
diagnosis and can be performed by well
trained nurses on an outpatient basis. It has
particular diagnostic value in HIV-infected
children in whom the diagnosis of intra-
thoracic tuberculosis is often complicated by
atypical manifestations and other HIV-
associated conditions.22 In addition to
providing rapid diagnostic confirmation by
cytomorphology and/or direct visualisation
of the infecting organism, FNAB samples
may be inoculated into relevant culture that
allows more accurate organism speciation
and drug sensitivity testing.20,23
This study confirms the diagnostic value
of FNAB in routine paediatric practice. It
also demonstrates that FNAB, using a
small-gauge needle, is rapid and safe even
in resource-limited settings. Well trained
nurse aspirators can perform superficial
aspirates as an outpatient procedure, redu-
cing the need for hospitalisation. Cytology
slides, once prepared and fixed, can be
transported easily for expert evaluation
elsewhere. FNAB is of particular value to
countries with limited resources and a high
prevalence of diseases such as tuberculosis
which can be treated successfully at primary
health care level, while identifying patients
who require referral to a regional or tertiary
care centre.
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SUMMARY 
OBJECTIVE  To evaluate the diagnostic yield and time to diagnosis of fine needle aspiration 
biopsy (FNAB) versus routine respiratory specimens collected from children with a palpable 
peripheral lymph node mass and symptoms suspicious of tuberculosis.  
DESIGN  We performed a retrospective review of laboratory records at Tygerberg 
Hospital over a 4-year period, from January 2003 to December 2006. All children (<13 years) 
in whom an FNAB and other mycobacterial specimens were collected as part of their 
diagnostic workup were included.  
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RESULTS  In 95 children the following specimens were collected; FNAB 95, gastric 
aspirates 142, other respiratory specimens 36, non-respiratory specimens 26. Mycobacterial 
disease was diagnosed in 70/95 (73.3%) patients. Children without respiratory specimens (n = 
6) and/or with M bovis BCG disease (n = 15) were excluded from comparative analysis. In the 
remainder, FNAB was positive in 45/74 (60.8%) versus any respiratory specimen in 29/74 
(39.2%; p <0.001). The mean time to bacteriologic diagnosis with FNAB was 7.1 days (95% 
CI 4.2-10.1) compared to 22.5 days (95% CI 15.8-29.1) for any respiratory specimen. 
CONCLUSION  FNAB is a simple, rapid and effective modality to achieve 
confirmation of mycobacterial disease in pediatric tuberculosis suspects with a palpable 
peripheral lymph node mass. 
 
INTRODUCTION 
Pediatric tuberculosis (TB) contributes significantly to the global TB disease burden.1-2 
Children suffer severe TB-related morbidity and mortality in endemic areas, but contribute 
little to disease transmission and the maintenance of the TB epidemic.1 Consequently, 
treatment of children has been a low priority in global TB control efforts, but the World 
Health Organization (WHO) produced guidance for the management of childhood TB in 2006 
calling for the evaluation of new techniques to improve the diagnosis.3 The Global Drug Fund 
made child-friendly TB treatment formulations available to poor countries since 2008.4  
The accurate diagnosis of pediatric TB remains a significant challenge, due to the low 
specificity of signs and symptoms, especially in human immunodeficiency virus (HIV)-
infected children, the difficulty of obtaining bacteriologic specimens and the paucibacillary 
nature of pediatric disease.5 New diagnostic tests for TB have been developed, such as T cell 
assays and nucleic amplification tests, but these are all poorly validated in children. 6 The 
47
  
ability to distinguish latent infection from active disease remains problematic, particularly in 
endemic areas with heavy disease burdens.  
An accurate bacteriologic diagnosis in children with TB is needed to initiate effective 
therapy and has become even more important with the transmission of multidrug-resistant 
(MDR) and extensively drug-resistant (XDR) TB to children.7-8 Obtaining bacteriologic 
specimens from children is difficult and diagnostic yield is usually low. Sputum smear 
microscopy is positive in less than 10-15% of children with probable pulmonary TB, with 
reported culture yields between 30-40%. 9-11 Various methods have been described to obtain 
respiratory specimens from children who are unable to expectorate, 12-14 with no international 
consensus on what is best.  
TB lymphadenitis is the most common extrapulmonary manifestation of TB in 
children from endemic areas,15 accounting for almost 50% of extrapulmonary disease.16  Fine 
needle aspiration biopsy (FNAB) is the diagnostic modality of choice in children with 
persistently enlarged cervical nodes in TB endemic areas.17 FNAB is increasingly utilized in 
paediatric oncology patients, 18-19 and multiple studies have reported the value of FNAB for 
TB diagnosis in adults, 20-22 but it remains underutilized as a diagnostic tool in TB suspects. 
The aims of this study were to compare the diagnostic yield and time to diagnosis of FNAB 
compared to routine respiratory specimens collected in child TB suspects with a palpable 
peripheral lymph node mass.   
 
METHODS 
We performed a retrospective review of laboratory records at Tygerberg Hospital, Cape Town 
South Africa, from January 2003 to January 2007.   Only children less than 13 years of age 
(eligible for access to pediatric services) were included.  Since this was a laboratory-based 
study we were unable to review clinical information and all diagnostic tests were requested at 
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the discretion of the attending clinician.  Standard practice at our institution is to refer 
children with a persistent peripheral lymph node mass (>1-2x1-2cm) for FNAB, while 
respiratory specimens are collected in most pediatric TB suspects. 
Children who underwent FNAB were identified using laboratory records of the 
National Health Laboratory Services.   Those in whom another specimen for mycobacterial 
culture was obtained within a 30 day time window either side of the FNAB collection date 
were included in the analysis. Cases with Mycobacterium bovis bacille Calmette-Guerin 
(BCG) disease were excluded from the comparative analysis.  These children typically present 
with right axillary adenitis ipsilateral to the vaccination site, which is nearly pathognomonic.23  
Inclusion of these children would have biased results in favour of FNAB. 
FNAB was done in the ward or as an outpatient procedure by a trained pathologist 
following standard protocol.24 The lymph node mass was stabilized by the pathologist 
performing the aspiration biopsy using a 23g or 25g needle attached to a 10ml syringe, 
applying constant suction of no more than 2ml. Two smears were prepared from each 
aspirate: one fixed with commercial cytology fixative for Papanicolaou staining and the other 
air-dried for Giemsa and ZN staining. Thereafter the needle and syringe was rinsed by 
withdrawing an aliquot of liquid growth media into the syringe and discharging the contents 
back into a mycobacterial growth indicator tube (MGIT, Beckton Dickinson, USA). The 
inoculated MGIT tubes were transported to the microbiology laboratory within 2 hours, where 
standard PANTA supplement was added and the tubes incubated for 42 days. Positive 
cultures were identified as M. tuberculosis complex by polymerase chain reaction (PCR).25  
In the cytology laboratory, smears were evaluated for adequacy, defined as sufficient 
cells and/or necrotic material to allow a definitive diagnosis.   A modified ZN stain was used 
on the Giemsa stained smears to detect acid fast bacilli.24 Fluorescence microscopy was 
carried out on Papanicolaou stained smears using a Zeiss Axiophot microscope with a 
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fluorescent attachment and a wide-band blue excitation filter (450–480 nm). Papanicolaou 
stained mycobacteria fluoresce as brilliant yellow bacilli, thin and slightly curved with polar 
enhancement and a length of 2.0 –2.7 microns.26 M. tuberculosis, M. bovis, M. bovis BCG and 
non-tuberculous mycobacteria (NTM) are morphologically indistinguishable, but in this TB-
endemic setting M. bovis is hardly ever detected on culture, M. bovis BCG usually has a 
clinical pathognomonic presentation, 27 and disease caused by NTM is relatively rare. 
Early morning gastric aspirates were obtained following overnight admission to the 
pediatric ward. A nasogastric tube was passed into the stomach and the contents aspirated; 5-
10 ml of normal saline inserted if required until a total volume of at least 5ml was aspirated. 
Gastric aspirates were placed in a sterile tube and neutralized with an equal volume of sodium 
carbonate. Induced sputa and/or nasopharyngeal aspirates were collected by a trained 
physiotherapist, but this was rarely done.  Sputum induction was undertaken after 3 hours of 
fasting. Children were pre-treated with 200ug of salbutamol via metered dose inhaler and 
spacer. A jet nebulizer attached to oxygen at a flow rate of 5 l/min delivered 5 ml of 5% 
sterile saline for 15 minutes. Thereafter chest physiotherapy was applied before obtaining 
sputum by expectoration or by nasopharyngeal suctioning, using a mucus extractor. 
Oropharyngeal suction was used if the child had excessive nasal secretions.  
All microbiology specimens were submitted to the laboratory within 6 hours. Smear 
microscopy, using either Ziehl-Neelsen or auramine stains, was only performed on 
expectorated sputum samples.  Following N-acetyl-L- cysteine - sodium hydroxide 
decontamination, sputum specimens were inoculated into MGIT and incubated for 42 days. 
Further procedures for identification of mycobacteria were as described for the FNAB 
samples. All procedures were carried out according to standard operating procedures in a 
Biosafety Level 2 laboratory. 
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The reference standard for disease on FNAB was cytomorphology consistent with 
mycobacterial infection plus mycobacteria visualized with ZN stain and/or autofluorescence, 
and/or if M. tuberculosis was identified on culture. Given the low rates of NTM in the study 
population culture negative cases with cytomorphological and mycobacterial proof of disease 
were included in the TB group. For respiratory specimens the reference standard was acid fast 
bacilli (AFB) detected on sputum smear microscopy or identification of M. tuberculosis by 
culture in at least one specimen. For comparative purposes multiple respiratory specimens 
were regarded as a single test procedure, since we aimed to compare the value of routine 
respiratory specimen collection as a diagnostic procedure to FNAB. 
We assessed whether the comparative bacteriological yield of FNAB (cytology and/or 
culture) was higher than other methods using Pearson’s chi-square (X2) and Fisher’s exact 
tests 28. All analyses were conducted using Statistica Version 8.29  Ethics approval was 
obtained from the Institutional Review Board of Stellenbosch University (N08/09/240).  
 
RESULTS 
FNAB and additional mycobacterial specimens were collected from 95 children, ranging in 
age from 2 months to 11 years. Figure 1 provides a flow diagram of patients and specimens 
included in the study. There was no significant difference in gender distribution (49 male vs. 
46 females) and 48% of children were less than one year of age. The HIV-infection status was 
unknown in 28 (29.5%) children while 33 (34.7%) were HIV-infected and 34 (35.8%) were 
HIV-uninfected. Mycobacteria were identified in 70 (73.7%) children. Table 1 reflects the 
biopsy site, bacteriologic yield and mycobacterial species identified on FNAB; no NTM were 
identified.  
Table 2 reflects the bacteriologic yield and mycobacterial species identified for all 
specimen types; of the 57 specimens speciated 41 (71.9%) were M. tuberculosis, 15 (26.3%) 
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M. bovis BCG and 1 (1.8%) NTM. A total of 143 gastric aspirates were collected from 80 
(84.2%) children, with only 11 children (13.8%) submitting the desired 3 specimens. 
Additional respiratory specimens were collected in 15 patients; of whom 7 (mean age 9.3 
years) provided expectorated sputum. Non-respiratory specimens, including cerebrospinal 
fluid, pus swabs and blood, were collected in 21 patients (26 specimens). All non-respiratory 
specimens, including 6 patients in whom no respiratory specimens were collected, and M 
bovis BCG cases were excluded from the comparative analysis.   M bovis BCG was isolated in 
15 children; in 2 cases the site of aspiration was soft tissue rather than an axillary lymph node. 
One third of these children (5 cases) had distant or disseminated BCG disease as evidenced by 
the isolation of M. bovis BCG from gastric and/or nasopharyngeal aspirates. All were 
immunocompromised: 4 were HIV-infected and the other had Severe Combined Immune 
Deficiency.  
Of the 45 patients diagnosed with TB using the defined FNAB reference standard, 36 
(80.0%) were confirmed to be M. tuberculosis on culture.  Of the 30 diagnosed from 
respiratory specimens, 29 (96.7%) were confirmed to be M. tuberculosis on culture and 1 
adolescent child was sputum smear (AFB) positive. For comparative purposes the collection 
of multiple respiratory specimens was regarded as a single test procedure. The bacteriological 
yield of FNAB compared to any combination of respiratory specimens is reported in Table 3; 
being higher compared to gastric aspirates (p < 0.001) and all respiratory specimens combined 
(p < 0.001).  
We also assessed differences in the mean time to diagnosis for FNAB versus the other 
specimen types (where time to diagnosis is time to bacteriologic confirmation from onset of 
the test procedure). Whether the timing of additional mycobacterial cultures occurred before, 
after or simultaneously with FNAB collection did not influence the significance of the yield 
or time to diagnosis comparisons.  Collecting multiple respiratory specimens was regarded as 
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a single test procedure. Accepting an average time to microscopy diagnosis of 2 days, FNAB 
(7.1 days, 95% confidence interval = 4.2 - 10.1 days) requires less than one-third the time of 
respiratory cultures (22.5 days, 95% CI = 15.8 – 29.1 days). This difference is illustrated in 
Figure 2. The one outlier is the child whose TB was confirmed by sputum smear-microscopy.  
The mean time to diagnosis for gastric aspirate culture (the most commonly performed test) 
was 21.4 days (95% CI = 15.2 – 27.6 days).  
 
DISCUSSION 
In the current study FNAB provided a better yield in child TB suspects with palpable 
peripheral lymph node masses than the collection of multiple respiratory specimens.   
Children referred with suspected mycobacterial lymphadenitis routinely have a tuberculin 
skin test (TST) performed and return to the clinic or hospital for this to be read within 48–72 
hours. If FNAB is performed with the initial visit, microscopy results should be available at 
the time of the return visit 48-72 hours later, enabling the commencement of TB therapy 
pending the results of culture and speciation.  
The true extent of the pediatric TB disease burden is poorly documented, since more 
than 80% of children with TB are sputum smear-negative and direct smear microscopy is 
often the only diagnostic modality available in countries with limited resources. The 
diagnostic dilemma is further compounded by the HIV pandemic, 27  HIV-associated disease 
and TB may have common clinical and radiological presentations, in addition tests for TB 
infection such as the TST and newer T-cell assays have poor sensitivity in 
immunocompromised children.2, 6, 10 Two to three fasting gastric aspirates or a single induced 
sputum specimen have traditionally been advised for bacteriological confirmation of TB.12 
However, the yields observed in everyday practice deviate considerably from those achieved 
under trial conditions, which emphasizes the value of “real-life” retrospective analysis.  
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The low number of patients in whom gastric aspirates were collected on 3 consecutive 
days reflects practical difficulties.  Severe limitations of in-patient beds and staff and the 
reluctance of parents to remain in hospital with their children for more than 1-2 days, since 
they often have other children at home to care for. In 5 children induced sputa and/or 
nasopharyngeal aspirates were collected as part of a separate specimen collection study, 
comparing the yield of gastric aspirates, nasopharyngeal aspirates and induced sputum. We 
included these specimens to provide a comprehensive overview of all the respiratory 
specimens collected.  Inclusion of these specimens may have introduced bias, but numbers 
were small and did not influence the outcome. If anything these additional specimens would 
have favored the bacteriological yield of routine respiratory specimens. Development of 
improved respiratory specimen collection techniques that can be performed on an outpatient 
basis require further exploration.  However our study demonstrates the value of FNAB as an 
outpatient diagnostic procedure in TB suspects with a palpable peripheral lymph node mass. 
Enlarged peripheral lymph nodes provide a valuable opportunity to establish a 
definitive diagnosis of TB in HIV-infected children.30  The majority of HIV-infected children 
with persistent lung disease have concurrent persistent peripheral lymphadenopathy, 30  which 
provides a neglected sample collection opportunity in this problematic group. In a recent 
South African study, 22 of 95 FNAB performed in mass lesions in HIV–infected children 
were positive for mycobacterial infection.31 FNAB has been established as an easy and 
reliable outpatient procedure for the diagnosis of palpable superficial masses in children, and 
is ideally suited for use in resource limited settings. It is simple, inexpensive, requires limited 
infrastructure and can be taught to medical and nursing staff.32 More widespread utilization is 
limited by a lack of experienced pathologists, but slides are easily transportable to regional or 
even international centers for diagnosis. 33 
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If the correct technique is followed, it is associated with minimal complications.33 
There were no adverse events or complications recorded with any of the FNAB’s performed 
during this study. In a previous study we demonstrated that using FNAB with 
cytomorphology, autofluorescence and culture, provided a rapid and definitive diagnosis in 
the vast majority of children.24 Culture alone produced a significantly lower yield, since it is 
influenced by factors such as inefficient sampling, contamination, variable bacterial load, and 
prior commencement of TB therapy.  Rapid microscopy confirmation was achieved in 34/45 
(75.5%) patients ultimately diagnosed with M tuberculosis using a combination of 
microscopy and/or culture positivity. Previous FNAB studies from this TB endemic setting, as 
well as the current study, demonstrated no NTM disease, 17, 24, 26, 31  while M bovis BCG was 
only cultured in children less than 2 years age with a clinically pathognomonic presentation.   
Although rapid microscopy diagnosis allows a fairly accurate diagnosis and permits 
immediate commencement of therapy, culture is advisable as this enables speciation and drug 
susceptibility testing. 
Compared to conventional respiratory specimens FNAB provided superior diagnostic 
yields and a significant reduction in time to TB diagnosis.   Rapid bacteriological diagnosis 
has important benefits for patient management, also in settings not endemic for TB where 
NTM adenitis may be more common.34-35 This study reviewed laboratory records only, 
therefore, we are unable to provide detailed clinical descriptions or explore potential 
differences in patient characteristics that may have influenced the sequencing and/or yield of 
various diagnostic tests.   However, it provides an assessment of every day (“real life”) 
practice without any intentional bias.  Despite these limitations, we believe FNAB should be 
regarded as a first line diagnostic modality in child TB suspects with a palpable peripheral 
lymph node mass. 
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Table 1 
 Mycobacteria isolated on culture and site of fine needle aspiration biopsy (FNAB) 
 
Site of FNAB 
Axillary node 
Mycobacteria 
isolated a  
Number 
(%) 
 
R L Not 
stated
Sub-
mandibular 
node 
 
Cervical 
node 
 
Salivary 
gland 
Soft 
tissue 
Site 
not 
stated 
All  51/95 
(54) 
11 5 6 8 31 4 5 25 
M. 
Tuberculosis   
36/51 
(71) 
5 5 2 8 31 4 3 22 
M. bovis 
BCG b     
15/51 
(29) 
6 0 4 0 0 0 2 3 
a No M. bovis or Non Tuberculous Mycobacteria (NTM) were isolated  
b13 (87%) of children <1 year of age  
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Table 2 
Specimen type, bacteriological yield and organisms cultured in 95 patients 
 
Consecutive 
specimens 
No (%) 
Specimen type Total 
number 
 
1st 2nd 3rd 
Culture 
positive  
No (%) 
M. tba 
 
No (%) 
BCGb 
 
No (%) 
NTMc 
 
No (%) 
FNAB 95 95 0 0 51 (54) 36 (71) 15 (30) 0 
Gastric 
aspirates 
143 80 52(65) 11(14) 39 (27) 30 (77) 8 (21) 1 (3) 
Induced sputum 15 10 5(50) 0 6 (40) 6 (100) 0 0 
Expectorated 
sputum 
11 7 3(43) 1(14) 5 (45) 5 (100) 0 0 
Nasopharyngeal 
aspirates 
10 7 3(43) 0 5 (50) 4 (80) 1 (20) 0 
Non–
respiratory  
26d 26 0 0 3 (12) 2(67)e 
 
1 (33)f 
 
0 
aM.tb – Mycobacterium tuberculosis; 
bBCG – Mycobacterium bovis bacilli Calmette-Guerin;  
cNTM – Non-tuberculous mycobacteria 
d21 patients, pus swabs, urine, CSF, blood cultures;  
eCerebrospinal fluid;  
fPus swab.  
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Table 3 
Bacteriologic yield of fine needle aspiration biopsy (FNAB) compared to routine 
respiratory specimens (M bovis BCG excluded) 
Routine respiratory specimens FNABa 
negative 
FNABa 
positive 
Total 
All gastric aspirates negative 25 19 44 
Any gastric aspirate positive 3 21 24 
Total 28 40 68 
All respiratory specimensb negative 26 19 45 
Any respiratory specimen positive 3 26 29 
Total 29 45 74 
aCytology and/or culture 
bIncludes gastric and nasopharyngeal aspirates, as well as sputum and induced sputum 
specimens 
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Figure 1 
Breakdown of patients and specimens included in the analysis  
 
95 patients 
with FNAB* 
and another 
specimen
143 gastric aspirates
26 non-respiratory 
specimens (excluded)
36 other respiratory 
specimens
15 patients with 
M. bovis BCG
6 patients, 
non-respiratory 
specimens only
74 patients 
with FNAB* 
and another 
respiratory specimen
68 patients with 
gastric aspirates
74 patients with
FNAB*
Excluded
12 patients with
other respiratory 
specimens  
 
*FNAB – Fine needle aspiration biopsy 
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Figure 2 
Time to diagnosis Fine Needle Aspiration Biopsy (FNAB) versus All respiratory 
specimens 
 
 
Y-axis – specify units “Days” 
X-axis – only “FNAB” & “All respiratory” 
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CHAPTER 5 
 
OPTIMISING CYTOPATHOLOGICAL DIAGNOSIS 
 
 
Mycobacterial Autofluorescence in Papanicolaou-Stained Lymph Node Aspirates: a 
Glimmer in the Dark? 
Colleen A Wright, Yvonne van Zyl, Steven M Burgess, Lucille Blumberg, Gladwyn Leiman. 
Diagnostic Cytopathology. 2004;30:257-60. 
 
Diagnosing Mycobacterial Lymphadenitis in Children Using Fine Needle Aspiration 
Biopsy: Cytomorphology, ZN Staining and Autofluorescence-making more of less. 
Colleen A Wright, Steven M Burgess, Mirjam van der Burg, D Geiger, Jeroen G Noordzij, Ben 
J Marais 
Diagnostic Cytopathology: 2008; 36: 245-251 
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Mycobacterial Autoﬂuorescence
in Papanicolaou-Stained Lymph
Node Aspirates:
A Glimmer in the Dark?
Colleen A. Wright, FRCPath,1* Yvonne van Zyl, C.T.,1
Steven M. Burgess, Ph.D.,2 Lucille Blumberg, M.D.,3
and Gladwyn Leiman, FRCPath1
This study was undertaken to determine the value of incorporating
ﬂuorescence into cytopathological evaluation of lymph node ﬁne-
needle aspiration (FNA) specimens suspected of harboring myco-
bacterial species. The study population consisted of 1,044 HIV-
positive and -negative patients referred for FNA to the
cytopathology unit of a South African medical school located in a
very high HIV prevalence region. Each aspirate was assessed on
routine Papanicolaou-stained slides for morphologic characteris-
tics of mycobacterial infection. The same glass slides were then
viewed under ﬂuorescent microscopy to determine the presence or
absence of mycobacterial autoﬂuorescence. Using multivariate
analysis, results of both cytology and ﬂuorescence were compared
with mycobacterial culture as the ﬁnal arbiter of the presence of
organisms. In this large clinical study, compared with culture,
cytomorphology showed sensitivity of 84.9%, but low speciﬁcity of
only 50.9%. Fluorescence demonstrated lower sensitivity of
65.9%, but improved speciﬁcity of 73.0%. Taken together, posi-
tivity of both cytology and ﬂuorescence improved speciﬁcity to
81.8%. Fluorescent microscopy is rapid, inexpensive, and cost-
effective; neither radioactive materials nor further staining are
required. It is felt that this methodology would be of diagnostic
beneﬁt if used on morphologically suspicious samples in areas
with a high prevalence of HIV and mycobacterial infections.
Appropriate therapy could be commenced within hours of FNA,
with reduction in the current number of patients lost to follow-up
while awaiting results of culture. The technique is readily extended
to other FNA types such as deep organ aspirates. Autoﬂuorescence
of organisms speciﬁcally requires usage of Papanicolaou staining;
the technique cannot be used in histopathologic specimens stained
with hematoxylin-eosin. Diagn. Cytopathol. 2004;30:257–260.
© 2004 Wiley-Liss, Inc.
Key Words: mycobacteria; tuberculosis; ﬂuorescence; cytodiagno-
sis; HIV
The human immunodeﬁciency virus (HIV) epidemic in
South Africa has attracted considerable attention. Preva-
lence ﬁgures in the general population are unknown, but
24.5% of women attending antenatal clinics nationwide are
HIV-positive; the corresponding ﬁgure for the province in
which this study was undertaken is 29.4% (Department of
Health National HIV and Syphilis seroprevalence survey of
women attending public antenatal clinics in South Africa,
2000; www.doh.gov.za/docs/reports/2000/hivreport.html).
It is estimated that more than 60% of medical admissions in
academic hospitals are due to opportunistic infections in
patients with acquired immunodeﬁciency disease (AIDS).
The most common of these opportunistic infections in South
African adults with AIDS is Mycobacterium tuberculosis
(MTB). In the year 2000, 150,696 new MTB cases were
reported to the national registry, including 31,058 extrapul-
monary infections (personal communication, Tuberculosis
Directorate, SA National TB Control Program). By 2001,
MTB incidence in the general population was approxi-
mately 300 per 100,000; at least 50% of new MTB cases
were in retroviral-positive patients (personal communica-
tion, SA National Department of Health). Dual HIV and
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MTB epidemics place overwhelming demands on health
care resources in any developing country. Expected life
span is reduced by AIDS (down from 68 years to 48 years
in South Africa between 1990 and 2000).1,2 By dominating
hospital admissions, the HIV/MTB population limits inves-
tigation and treatment of non-HIV patients with potentially
curable disease entities compatible with normal longevity.
MTB diagnosis may be challenging, even in high preva-
lence areas; it is modiﬁed by HIV status and compounded
by atypical symptoms, overlap in presentation of other
opportunistic infections, frequency of extrapulmonary in-
volvement, and rapid progression.3
Traditionally, laboratory diagnosis of mycobacterial infec-
tion has been the purview of the microbiologist; it has relied on
positive culture or microscopic recognition of the organism by
Ziehl-Nielsen staining.4 Fluorescence microscopy using aura-
mine-rhodamine was described as early as 1937 and generally
has been shown to be superior to Ziehl-Nielsen staining,5–7 but
involves the use of toxic and carcinogenic substances. A sub-
stantial beneﬁt would derive from any new, inexpensive, ex-
posure-free diagnostic procedure, enabling early commence-
ment of anti-MTB treatment. Mycobacteria (as well as
Pneumocystis carinii, fungi, and certain bacteria) show bril-
liant autoﬂuorescence in Papanicolaou-stained smears.8–10 The
method is quick and inexpensive and can be focussed on those
specimens felt to harbor the above infections on morphologic
grounds. This suggests that ﬂuorescence microscopy of Papa-
nicolaou-stained smears could provide a rapid, safe, and inex-
pensive technique for conﬁrmation of mycobacterial infection
in cytological specimens. The present study explores this op-
portunity by investigating the ability of cytomorphology and
ﬂuorescence microscopy of Papanicolaou-stained smears from
superﬁcial lymph nodes obtained by ﬁne-needle aspiration
(FNA), individually and together, to identify mycobacterial
infections.
Materials and Methods
A prospective study was performed in the teaching hospitals of
the University of the Witwatersrand in Johannesburg, South
Africa, during the period January 1998 to December 2001. The
sample consisted of 1,044 superﬁcial lymph node aspirates
from patients with clinically suspected mycobacterial lymph-
adenopathy. In this center, retroviral serology is not performed
without patient consent; serology was thus not available in
many cases. In the 330 cases in which retroviral status was
known, 318 (96%) were positive; a high proportion of the
remaining patients were clinically suspected to be retrovirus-
positive. Patients were referred to FNA clinics operated by the
cytopathology unit at four teaching hospitals. Procedures were
performed using 22 gauge needles attached to 10 ml syringes.
At least two needle passes were performed on each node
aspirated. Direct smears were made and were either air-dried
for Diff-Quik staining or ﬁxed with commercial spray ﬁxative
for Papanicolaou staining. Onsite rapid staining was not un-
dertaken. The needle was rinsed in BACTEC 12B medium
(Becton-Dickinson, Mountain View, CA), a commercially
manufactured mycobacterial culture system. Slides were re-
turned to the central cytopathology laboratory for same-day
processing.
The air-dried Diff-Quik-stained and alcohol-ﬁxed Papa-
nicolaou-stained smears were screened and evaluated for
adequacy and content. All neoplastic samples were ex-
cluded from the study, as were inadequate slides and those
showing benign nonreactive, noninﬂammatory morphology.
The remainder were reported as cytologically suggestive
(positive) or nonsuggestive (negative) of mycobacterial
lymphadenitis. This cytomorphologic evaluation was made
on previously established criteria: amorphous granular ne-
crotic debris, epithelioid histiocytes, and multinucleated
Langhans-type giant histiocytes, in a background popula-
tion of reactive lymphocytes and plasma cells. In the pres-
ence of AIDS, the cytological picture is more frequently that
of necrosis only, or necrosis associated with an acute in-
ﬂammatory inﬁltration, without attendant lymphocytic or
histiocytic components.
Without any additional processing, the Papanicolaou-
stained smears were then screened by one author (Y.v.Z.)
using an Olympus BX40 microscope with a ﬂuorescent
attachment and the following ﬁlters: wide-band blue exci-
tation ﬁlter (450–480 nm), dichromatic splitter (500 nm),
and barrier ﬁlter (515 nm). Slides were viewed at 400
magniﬁcation. This displayed the MTB organisms as bril-
liant yellow ﬂuorescent rods, which were thin and slightly
curved with light ends and a uniform length of 2.0–2.7
microns (Fig. C-1). Mycobacterium tuberculosis is differ-
entiated from Mycobacterium avium, which is shorter (1.2–
1.8 microns) and variably ﬂuorescent.
Fig. C-1. Dark-ﬁeld illumination of characteristic MTB organism demon-
strating autoﬂuorescence in a lymph node aspirate (Papanicolaou,1,000).
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Results
Retroviral status (where known) and the diagnostic outcome
of each of the three tests (i.e., cytomorphology, ﬂuores-
cence, and culture) were code-captured in a standard porta-
ble computer spreadsheet using a standard indicator coding
scheme (1  positive; 0  negative). The laboratory’s
unique case reference number was also captured for quality
control purposes. Detailed results appear in Tables I–III.
The results indicate a strong and highly signiﬁcant associ-
ation between cytology and culture diagnoses (Cramer’s
V  0.59; P  0.001) and a virtually equivalent association
between ﬂuorescence and culture (Cramer’s V  0.57; P 
0.001). Thus, the overall accuracy of the techniques, sepa-
rately and together, is virtually identical at almost 70%.
Cytology and ﬂuorescence offer differing beneﬁts as re-
gards sensitivity and speciﬁcity. Cytology is suggestive of
84.9% of culture-positive cases, yields few false negatives,
but has low speciﬁcity of 50.9%. Fluorescence has lower
sensitivity of 65.9%, yields few false positive readings, and
thereby raises speciﬁcity to 73.0%. Taken together, cytol-
ogy and autoﬂuorescence reﬁne the diagnostic group, incor-
porating lower sensitivity at 56.7%, but signiﬁcantly im-
proving speciﬁcity to 81.8%. Clinical implications are that
three of ﬁve TB patients undergoing FNA could be placed
on appropriate and immediate antituberculous therapy. At a
later stage of patients so medicated, one of four would not
be conﬁrmed on traditional culture as harboring active my-
cobacterial infection.
Discussion
The diagnosis of tuberculosis by cytomorphology is not
new. It is a necrotizing granulomatous infection, which
cytologically demonstrates the microscopic equivalent of
caseous necrosis, i.e., a granular-appearing necrotic back-
ground, together with mature lymphocytes, tangles of epi-
thelioid histiocytes, and giant multinucleated Langhans-
type histiocytes. This cytological appearance, however, is
neither sensitive nor speciﬁc for MTB. In recent years, the
advent of HIV-associated tuberculosis has altered the char-
acteristic cytologic picture, mainly by paucity or even ab-
sence of cellular response, i.e., fewer epithelioid and
multinucleated histiocytes. Recent literature has shown that
FNAs, particularly from large nodes with necrotic centers,
may contain no cellular response at all, i.e., no epithelioid or
multinucleated histiocytes, and may even lack lymphocytes
if the entire node has undergone necrosis.11,12 Aspirates may
then be entirely necrotic or may contain debris together with
a secondary inﬂux of neutrophils. The cytology then resem-
bles an abscess more than it does classic tuberculosis. How-
ever, in high-incidence regions, sufﬁcient experience has
now been gained with new and varied presentations of
tuberculosis in lymph node aspirates to raise the cytological
suspicion of MTB in appropriate clinical settings. Ziehl-
Nielsen staining may be performed on FNAs; while very
speciﬁc, this test lacks sensitivity, as organisms may be
extremely sparse and difﬁcult to visualize. Therefore, it has
become routine to submit needle rinses or separate needle
passes in appropriate media to microbiology, where direct
microscopy is performed, together with traditional culture.
If all tests are negative prior to culture becoming positive,
deﬁnitive diagnosis may be delayed for up to 6 weeks. In a
country or region in which MTB is so prevalent, treatment
delays of this nature are unacceptable, as they result in
continued presence of infected and infectious patients in
their communities, where further spread is likely.
To alleviate this, ﬂuorescence, utilizing ﬁxed Papanico-
laou-stained cytologic material, becomes appealing for
rapid and cost-effective diagnosis of MTB. When judged
against traditional culture, the sensitivity in this study of
cytodiagnosis (84.9%), and that of autoﬂuorescence of Pa-
panicolaou-stained material (65.9%), may not reach levels
of sensitivity as attained in the diagnosis of malignancy by
FNA. These sensitivity values are, however, higher than
those quoted by Kupper et al.9 in their work on Mycobac-
terium kansasii. In terms of providing clinicians in over-
crowded hospital settings with same-day working diagnoses
on which immediate antituberculous treatment can be com-
menced, it is our feeling that the routine addition of ﬂuo-
Table I. Comparative Results of MTB Detection by Cytodiagnosis and
by Culture*
Cytodiagnosis
Culture
Negative Positive Total
Negative 228 (22%) 90 (8%) 318 (31%)
Positive 220 (21%) 506 (49%) 726 (70%)
Total 448 (43%) 596 (57%) 1,044 (100%)
*Sensitivity, 84.9%; speciﬁcity, 50.9%; negative predictive value, 71.7%;
positive predictive value, 69.7%; accuracy, 69.3%.
Table II. Comparative Results of Detection of MTB by
Autoﬂuorescence and by Culture*
Fluorescence
Culture
Negative Positive Total
Negative 327 (31%) 203 (19%) 530 (50%)
Positive 121 (12%) 393 (38%) 514 (50%)
Total 448 (43%) 596 (57%) 1,044 (100%)
*Sensitivity, 65.9%; speciﬁcity, 73.0%; negative predictive value, 67.7%;
positive predictive value, 76.5%; accuracy, 69.3%.
Table III. Summary of Statistical Analyses for Detection of MTB by
Cytodiagnosis and by Autoﬂuorescence, Separately and Together (%)
Cytodiagnosis Autoﬂuorescence Both
Sensitivity 84.9 65.9 56.7
Speciﬁcity 50.9 73.0 81.8
Negative predictive value 71.7 61.7 58.7
Positive predictive value 69.7 76.5 80.5
Accuracy 69.3 69.3 69.4
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rescence to microscopy in FNAs has much to offer. It can be
regarded as a one-stop test, performed if necessary on one
glass slide, seen in one laboratory unit, with the ﬁnal report
available within hours of the FNA procedure. Diagnosis is
accomplished without reprocessing from transport medium
for direct evaluation and for culture, as occurs in microbi-
ology. It also avoids the use of radioactive substances that,
as indicated previously, carries some degree of morbidity
for laboratory workers.9 The percentage of cytology/ﬂuo-
rescence patients subsequently found to be culture-nega-
tive (18.2% of those who might be placed on anti-MTB
therapy using this dual positivity as an indication; 8% of the
entire group referred for FNA) would appear to justify the
immediate commencement of such therapy, if clinically
consistent. Antituberculous therapy can be stopped if culture is
found to be negative, or if clinicoradiological assessment
deems the disease process not to be tuberculous in nature.
Culture was used in this study as the ﬁnal arbiter of MTB
infection. However, while it is the most accurate means of
diagnosis available, it too is beset by an irreducible false
negative rate. It is thus possible that some patients who are
positive by cytology and/or ﬂuorescence in this study, but
negative by subsequent culture, did in fact have tuberculo-
sis. Only a long-term prospective clinicoradiologic and cy-
tologic study incorporating review of patient records and
ultimate response to therapy over time could answer this
dilemma. An investigation of that nature is outside the
capabilities of this laboratory-based study.
There are ways in which the sensitivity of diagnostic
ﬂuorescence could be improved. A recent study13 utilized
automated Papnet screening technology for the identiﬁca-
tion of small rare mycobacterial organisms stained by the
auramine-rhodamine method. However, for most laborato-
ries, an innovation of that type would be ﬁnancially unat-
tainable. On the other hand, the mere addition of careful
dark-ﬁeld illumination, searching for ﬂuorescence as re-
ported here, is feasible in most laboratories.
Compared with culture techniques, ﬂuorescence yielded a
number of false positive cases in this study. Bacterial forms
other than MTB are known to exhibit autoﬂuorescence; it is
thus possible that incorrect identiﬁcation of these very small
organisms will be made. Kupper et al.8 has suggested that a
minimum number of eight organisms be required for posi-
tive diagnosis. In our experience in retroviral positive pa-
tients, MTB organisms are profuse and theoretically would
be easier to identify. The ﬂuorescent staining properties of
Mycobacterium avium intracellulare are more variable that
than of MTB. In 596 culture-positive cases in this study,
only 6 were mycobacteria other than Mycobacterium tubercu-
losis. There is, therefore, no replacement for experience and
familiarity with the morphology of the organisms and scrupu-
lous attention to detail when evaluating ﬂuorescent bacteria.
It cannot be sufﬁciently emphasized that ﬂuorescence of
organisms is appropriate only to material stained with the
Papanicolaou stain. The results of the above study cannot,
for example, be transferred to cell block or histopathologic
sections stained with hematoxylin-eosin. The particular in-
gredient of the Papanicolaou stain that is thought to permit
autoﬂuorescence is most likely EA50 or EA65. Because of
the capacity of the Papanicolaou stain to permit autoﬂuo-
rescence, cytopathologists ﬁnd themselves in the unique
position of extending the usual capability of cytodiagnosis
to include identiﬁcation of ﬂuorescent organisms, such as
Mycobacterium tuberculosis, Pneumocystis, and Cryptococ-
cus. In high-incidence areas of tuberculosis and of AIDS,
this method may prove to be diagnostically useful on a scale
larger than previously anticipated.
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Diagnosing Mycobacterial
Lymphadenitis in Children Using
Fine Needle Aspiration Biopsy:
Cytomorphology, ZN Staining and
Autofluorescence—Making More of Less
Colleen A. Wright, F.R.C.Path.,1* Mirjam van der Burg, Ph.D.,1{ D. Geiger, M.Sc.,1
Jeroen G. Noordzij, Ph.D.,2{ Steven M. Burgess, Ph.D.,3 and Ben J. Marais, Ph.D.2
Although the incidence of TB has stabilized or declined in most
world regions, it is increasing in Africa, Southeast Asia, and the
Eastern Mediterranean, fuelled by the HIV pandemic. More than
4,000 people died daily from TB-related illnesses in 2005. TB is
a major cause of childhood morbidity and mortality in these
developing countries, and there is an urgent need for rapid and
definitive modalities for mycobacterial diagnosis in children.
This prospective study in Tygerberg Hospital, Cape Town, South
Africa, evaluates the ability of fine needle aspiration biopsy
(FNAB) to diagnose mycobacterial lymphadenitis in children,
using cytomorphology, autofluorescence on Papanicolaou
stained smears, Ziehl-Nielsen (ZN) staining and/or culture.
FNABs were performed on 200 children, and 25 (12.5%) aspi-
rates were inadequate. Cultures were positive in 79/175 (45%);
Mycobacterium tuberculosis was identified in 61 and Mycobacte-
rium bovis BCG in 18 cases. Using culture as the gold standard,
the concordance of the different techniques was as follows: cyto-
morphology 70%, ZN staining 73%, and autofluorescence 68%.
Using an alternative gold standard (culture positive and/or sug-
gestive cytomorphology plus positive autofluorescence or ZN
smear), the ‘‘true’’ diagnostic performance of the various techni-
ques was as follows: cytomorphology—sensitivity 78%, specific-
ity 91%, positive predictive value (PPV) 93%, ZN staining - sen-
sitivity 62%%, specificity 97%, PPV 97%; autofluorescence—
sensitivity 67%, specificity 97%, PPV 97%; and culture—sensi-
tivity 75%, specificity 100%, and PPV 100%. FNAB was shown
to provide a rapid and definitive diagnosis in the majority of
cases of suspected tuberculous lymphadenitis in children, based
on cytomorphology and identification of the organism. Diagn.
Cytopathol. 2008;36:245–251. ' 2008 Wiley-Liss, Inc.
Key Words: fine needle aspiration biopsy; children; mycobacte-
ria; tuberculosis; lymph node; HIV
Tuberculosis (TB) was declared a global emergency by
the World Health Organization (WHO) in 1993.1 Since
then, the incidence of TB has stabilized or declined in
most world regions, except Africa, Southeast Asia, and
the Eastern Mediterranean, where the impact of the pan-
demic is staggering.2 Between 2000 and 2005, new TB
cases increased worldwide by 6%, to more than 24,000
new TB cases daily. More than 84% of these cases were
located in sub-Saharan Africa and Asia. Even though TB-
related deaths declined by 11% between 2000 and 2005,
more than 4,000 people died daily from TB-related ill-
nesses in 2005. It is fair to say that TB remains an emer-
gency in those countries that can least afford the costs of
diagnosing and treating its victims.
TB is a major cause of childhood morbidity and mortal-
ity in developing countries.3,4 Children below 3 years of
age are particularly vulnerable because their immature
immune systems make them susceptible to more severe
disease manifestations, such as miliary TB and TB menin-
gitis.5,6
In 1989, the WHO estimated the worldwide incidence
of TB in children to be 1.3 million per year with 450,000
children dying from TB-related illnesses in that year.7 In
2000 there were 8.3 million new cases of TB estimated
worldwide, with 11% occurring in children younger than
15 years of age.8 As alarming as these estimates are, they
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may grossly underestimate the incidence of TB in chil-
dren because the WHO estimates are based on smear pos-
itive cases and more than 80% of children with TB are
not smear positive.9 In South Africa, as many as 40% of
all cases of TB occur in children.8
The diagnosis of TB in children is particularly chal-
lenging for three reasons.10–12 First, sputum and alterna-
tive specimens (e.g., gastric aspirates) are difficult to ob-
tain and have a poor diagnostic yield (i.e., typically as
low as 30–40% even with more sensitive mycobacterial
culture).9 Second, culture has limitations. Although direct
culture inoculation at the bedside gives a high yield,13 it
takes 1–6 weeks to deliver a final result. Culture also fails
to differentiate between the various mycobacteria and,
thus, requires additional polymerase chain reaction
(PCR)-based testing for accurate speciation. Third,
although chest radiography is considered reasonably accu-
rate and practical for diagnosis of intrathoracic TB in
children with suspicious symptoms, it has many limita-
tions. Most importantly, it is not helpful in the diagnosis
of extrathoracic TB without concurrent intrathoracic man-
ifestations, a combination common in children.2,10 For
example, a recent South African national study reported
that 39,739/270,178 (14.7%) of new TB cases in 2005
were extrapulmonary TB.2 A Cape Town study reported
that 72/439 (16.4%) of children treated for active TB had
extrathoracic disease and 65.4% of the positive cases had
no concurrent intrathoracic disease manifestations.11 TB
lymphadenitis was the most common form of extrathora-
cic TB in the Cape Town study and nearly all cases with
peripheral TB lymphadenitis presented with enlarged
cervical lymph nodes,11 consistent with previous
research.12,14 TB lymphadenitis is the most common
cause of persistent cervical lymphadenopathy in this TB
endemic area.13 The challenge of diagnosing TB in chil-
dren highlights the urgent need for rapid and definitive
mycobacterial diagnosis in children with persistent cervi-
cal lymphadenopathy, which is the focus of our
research.
Fine-needle aspiration biopsy (FNAB) has many qual-
ities that make it an excellent diagnostic procedure in
children with persistent superficial lymphadenopathy,
especially in TB-endemic countries with limited resour-
ces. FNAB is a simple technique to perform. It is mini-
mally invasive, safe and has very limited side effects
when performed with a small gauge needle (e.g., no sinus
formation). It can be performed as an outpatient proce-
dure by trained medical or paramedical staff.13,15 Collect-
ing a representative sample of material from a lymph
node allows cytomorphological analysis and identification
of the organism by direct microscopy and/or culture.
The diagnostic value of various microscopy techniques
used to evaluate an FNAB sample has not been fully
evaluated in children. A pilot study of 65 aspirates in
children using cytomorphology, ZN staining, and auto-
fluorescence as diagnostic modalities had showed 92.3%
concordance with culture when all three modalities were
combined.16 The current study aimed to compare the
diagnostic performance of cytomorphology, ZN stain-
ing, autofluorescence, and culture in a large cohort of
children.
Materials and Methods
A prospective study was performed in Tygerberg Hospital
during the period of January 2003 to June 2005. All chil-
dren (a) less than 13 years of age (eligible for access to
pediatric services), (b) with persistent superficial lymph-
adenopathy not responsive to first line antibiotic therapy,
and (c) with a clinical suspicion of mycobacterial infec-
tion routinely referred for diagnostic FNAB were included
in the study.
The referring clinician was requested to give oral seda-
tion and analgesia 30 minutes prior to the procedure,
which was performed in the ward or outpatient clinic
with the assistance of the referring doctor and/or nursing
staff. Consent was obtained from the legal guardian
accompanying the child. The FNAB was performed using
a 23-g or 25-g needle attached to a 10-cc syringe. The
skin was cleaned using an alcohol swab, the child firmly
immobilized and the node stabilized by the aspirator
while performing the aspirate using no more than 2-cc
suction. Standard precautions were taken to minimize any
complications. Two smears were prepared from each aspi-
rate and the needle and syringe rinsed in mycobacterial
growth tube indicator (MGIT, Beckton Dickinson, USA)
medium for mycobacterial culture. One smear was spray
fixed with commercial cytology fixative for Papanicolaou
staining and the other air-dried for Giemsa staining.
Smears were sent to cytology for cytomorphology, auto-
fluorescence, and ZN staining.
The stained smears were screened and evaluated for ad-
equacy and diagnosis using each of the modalities
described. Cytological results were reported as nonspecific
reactive lymphadenopathy or cytologically consistent with
mycobacterial infection, based on specific morphological
criteria which have been previously described.17–19 Im-
mune competent patients with TB present with the more
classical morphological picture of epithelioid granulomata
and epithelioid histiocytes in a background of reactive
lymphocytes and plasma cells (Fig. C-1). A small amount
of amorphous necrosis and occasional giant cells may be
present. Patients with tuberculosis who are immune com-
promised have smears showing abundant ‘‘dirty’’ necrosis
in which neutrophils and cellular debris are prominent
(Fig. C-2). There is a spectrum of morphology between
these extremes, and aspirates from patients with mycobac-
terial lymphadenitis may occasionally show morphologi-
cal features of suppurative acute lymphadenitis.
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In patients with lymphadenitis due to M bovis BCG,
histiocytes with abundant foamy cytoplasm are present.
Because of the considerable morphological variation, the
fact that patients with mycobacterial infection may pres-
ent with aspirates showing nonspecific lymphadenitis and
that other organisms such as fungal infections may pres-
ent a similar clinical and morphological picture, staining
for mycobacteria was performed an all aspirates, irrespec-
tive of the cytological diagnosis. ZN stains were per-
formed on one of the Giemsa stained slides according to
a slightly modified technique. The smears were differenti-
ated in 3% acid alcohol for 1 minute and counterstained
with 1% methylene blue for 10 seconds only (Fig. C-3).
One of the Papanicolaou stained slides was screened
using a Zeiss Axiophot microscope with a fluorescent
attachment and a wide-band blue excitation filter (450–
480 nm). Mycobacteria auto fluoresce as brilliant yellow
bacilli, thin and slightly curved with polar enhancement
and a uniform length of 2.0–2.7 lm (Fig. C-4).20 Despite
identification of the mycobacteria on ZN staining and/or
autofluorescence, Mycobacterium tuberculosis, Mycobac-
terium bovis BCG, and Mycobacterium avium–intracellu-
lare are morphologically indistinguishable.
Culture samples were inoculated into 7H9 liquid growth
medium at the bedside and sent directly to microbiology,
according to standard protocol. Cultures were incubated at
378C for 8 weeks or until indicated as positive, according
to standard protocol using the MGIT system (Becton Dick-
enson, Cockeysville, MD). All mycobacterial isolates were
identified as Mycobacterium tuberculosis, Mycobacterium
bovis BCG or nontuberculous mycobacteria (NTM) by po-
lymerase chain reaction (PCR) testing.
Fig. C-1–C-4. Fig C-1. Poorly formed granuloma consisting of epithelioid histiocytes and lymphocytes in a clean background, consistent with tubercu-
lous lymphadenitis in an immune competent child (Papanicolaou, 3400). Fig. C-2. Numerous neutrophils and karyhorrectic debris in a necrotic back-
ground, consistent with tuberculous lymphadenitis in an immune compromised child. (Papanicolaou, 3400). Fig. C-3. Modified ZN stain in a lymph
node aspirate from an immune compromised child, demonstrating the overwhelming load of mycobacterial organisms present (Papanicolaou, 3400).
Fig. C-4. Autofluorescence of mycobacteria in a lymph node aspirate (Papanicolaou, 31,000 with a wide-band blue excitation filter).
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Parents gave written informed consent for study partici-
pation and ethics approval was obtained from the Institu-
tional Review Board of Stellenbosch University.
Results
FNABs were collected from 200 children, and 25 (12.5%)
aspirates were inadequate. Samples from 175 children
were included in the analysis. Patient demographics and
sample data are reported in Table I.
The results for the three diagnostic techniques were as
follows. Cultures were positive in 79 cases (45%): 61
Mycobacterium tuberculosis, 18 Mycobacterium bovis
BCG and no NTM positive samples. The median age of
children with positive cultures was similar to those with
negative cultures (2 years). However, all children with
Mycobacterium bovis BCG were less than 2 years of age,
the majority 16/18 (89%) being infants.
Table II compares the diagnostic performance of the
three microscopy techniques cytomorphology, autofluores-
cence, and ZN staining alone and in combination to cul-
ture as the gold standard. However, culture is probably
not the optimal gold standard, as a false negative culture
is not uncommon. The previous pilot study investigated
the culture negative cases in which any of the other
modalities were positive and identified eight false culture
negative cases that were clinically assessed as having TB
and responded to TB therapy.16 Patients may commence
TB treatment prior to referral for FNAB. Therefore, using
culture alone as the gold standard may be flawed, and we
identified an alternative gold standard as culture positive
or positive cytomorphology plus positive autofluorescence
or ZN staining.
Using this alternative gold standard improved the diag-
nostic performance of all three modalities. The concord-
ance rate with the new standard is 83% for cytomorphol-
ogy, 79% for autofluorescence, 76% for ZN staining, and
84% for culture (Table III). The sensitivity, specificity,
and overall efficacy of these diagnostic modalities are
shown in Table IV.
Discussion
In many low- and middle-income countries with limited
resources, the diagnosis of TB is still based on poorly
validated symptom-based algorithms, often not resulting
in a definitive diagnosis.21 FNAB provides a rapid and de-
finitive tissue diagnosis in the majority of children with
superficial lymphadenopathy. This study demonstrates that
it also permits confirmation of the presence of mycobacte-
ria, with fluorescence microscopy being more sensitive
than ZN staining. Recent studies have demonstrated that
light emitting diode (LED) technology provides a cheap
and reliable light source with minimal energy require-
ments that performs as well as the traditional mercury
vapour lamp used in this study.22,23 To date, the high cost
and short half-life of the mercury vapour lamp has limited
the availability of fluorescence microscopy in healthcare
systems with constrained financial resources.23
The 2007 WHO report noted that over half of the popu-
lations in the African, South-East Asia, and Western
Pacific regions had limited coverage of culture services.
Most countries had neither national policies to expand
culture and sensitivity testing services nor the technical
capacity to implement and support such services. In South
Africa., there were 143 laboratories performing smear mi-
croscopy and 18 laboratories performing culture.2 This is
mainly due to centralization of the more expensive and
Table I. Demographics and Sample Characteristics
Numbers Percentage
Number of aspirates 200
Inadequate samples 25 12.5
Specimens included in analysis 175 87.5
Age
1 year 75 42.9
2–4 years 48 27.4
5–9 years 32 18.3
10 years 20 11.4
Gender
Male 82 46.9
Female 93 53.1
Diagnosis
Malignancy 0 –
Nonspecific node l 86 49.1
Consistent with mycobacterial infection 89 50.1
Fluorescence positive 73 41.7
ZN positive 68 38.9
Culture positive mycobacterial infection 79 45.0
Organism isolated
M. Tuberculosis 61 77.0
M. bovis BCG 18 23.0
Nontuberculous mycobacteria 0 –
Table II. Concordance of Diagnostic Modalities with Culture as Gold Standard
Cytology Fluorescence ZN Any diagnostic modality Any two diagnostic modalities
Positive agreement 33% 27% 29% 39% 30%
Negative agreement 37% 41% 45% 34% 39%
Concordant 70% 68% 73% 73% 69%
False positive 18% 14% 10% 21% 15%
False negative 12% 18% 17% 6% 15%
Pearson v2 29.33 21.48 36.19 43.21 24.86
Phi 0.41 0.35 0.46 0.50 0.38
n ¼ 175; all Pearson v2 statistics are significant at P  0.0001.
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sophisticated culture techniques. Centralization is also a
feasible option in resource constrained healthcare systems
because FNAB can be done as an outpatient procedure by
trained medical or paramedical personnel and correctly
fixed slides can be sent to specialized diagnostic facilities
for cytological evaluation and fluorescent microscopy.
The diagnosis of TB lymphadenitis is increasingly com-
plicated by the HIV pandemic. HIV infection, in children
and adults, is a major contributor to the escalating TB
epidemic worldwide.24–26 At the end of 2000, it was esti-
mated that there were 11.5 million HIV-infected people
coinfected with TB in sub-Saharan Africa.1 In 2005,
South Africa with 0.7% of the world’s population had
19% of all cases of TB in adult HIV-positive people.2
Infection with the HIV virus is estimated to increase the
lifetime risk of a patient infected with M tuberculosis of
developing TB by 10-fold to 50%.1 Children are not
exempt from this burden.
A hospital-based study from Zambia demonstrated a
HIV seroprevalence rate in children with TB to be >70%,
while the minority of childhood TB cases were HIV nega-
tive.27 In HIV-infected children the diagnosis of intra-
and/or extrathoracic TB is even more difficult due to con-
comitant chronic diseases such as lymphocytic interstitial
pneumonitis (LIP) and other opportunistic infections.27,28
Persistent peripheral lymphadenopathy in children is com-
mon and is itself a criterion for the classification of HIV-
related disease in children.29,30 In HIV-infected children,
peripheral lymphadenopathy may be associated with
many pathological entities, from infections to neoplasia.
A study from South Africa demonstrated that the ma-
jority of HIV-infected children with persistent lung dis-
ease (PLD), due to a variety of causes, have persistent
peripheral lymphadenopathy (PPL) and PPL was present
in many children with pulmonary TB (PTB).31 Thus,
enlarged peripheral lymph nodes were identified as impor-
tant specimen collection sites to consider in establishing a
definitive diagnosis of TB in HIV-infected children.31 In
HIV-infected children, it is even more important to estab-
lish a mycobacteriologic diagnosis, as tuberculin skin
tests, symptom-based approaches, and radiology are less
helpful,28 and these children may be at an increased risk
of exposure to drug resistant strains of TB.
Disseminated BCG disease is a rare complication of
BCG vaccination, classically only described in children
with severe congenital immune deficiencies. However,
HIV-infected children also appear to be at high risk.32,33
BCG vaccination may also associated with local compli-
cations such as abscess formation at the vaccination site
and/or regional lymphadenitis, with reported rates of
lymphadenitis in BCG recipients ranging from 0.5% to
17.6%.24 In South Africa, the recent change in vaccine
policy in July 2000 from percutaneous Tokyo strain BCG
to intradermal Danish strain BCG vaccine has seen a
number of adverse events reported in both HIV-infected
and immune competent children.32 In children with axil-
lary or other regional lymph node enlargement, FNAB
offers a simple first line diagnostic procedure to confirm a
diagnosis of BCG disease.
FNAB is widely utilized in the diagnosis of palpable
masses including peripheral lymphadenopathy, and its
value in the diagnosis of mycobacterial lymphadenitis in
adults is well documented.17–20,34,35 It offers a simple,
effective, and safe modality for obtaining a representative
sample of material from a lymph node, permitting cyto-
logical evaluation, identification of the organism by mor-
phology, culture and molecular techniques such as the
polymerase chain reaction (PCR). Cytomorphology is
simple, but not specific, as other opportunistic infections
may present with similar cytological changes and the
quality of the smear is operator dependent.17,19 With good
clinical triage of patients, its sensitivity and specificity
can be increased. In our study, cytomorphology achieved
a sensitivity of 78% and a specificity of 91%.
ZN staining, even in good laboratories, is generally
regarded as insensitive, identifying organisms in only
about 20% of culture positive samples.35 This may be
dependent on experience, the staining, and the bacterial
load. In our study, ZN staining achieved sensitivity of
62% but with a specificity of 97%. Although autofluores-
cence is simple, sensitive, and inexpensive, it is not
widely used. It requires a fluorescent microscope, which
may not be readily available, but has the advantage of not
requiring additional stains and is therefore inexpensive
and rapid. In our study, it performed similar to ZN stain-
Table III. Concordance of Diagnostic Modalities with New Gold
Standard Culture Positive or Cytomorphology Positive Plus Positive
Autofluorescence or ZN
Cytology Fluorescence ZN Culture
Positive agreement 47% 41% 38% 45%
Negative agreement 36% 38% 38% 39%
Concordant 83% 79% 76% 84%
False positive 3% 1% 1% 0%
False negative 13% 20% 23% 15%
Pearson v2 81.02 70.59 61.99 93.74
Phi 0.68 0.64 0.60 0.73
n ¼ 175; all Pearson v2 statistics are significant at P  0.0001.
Table IV. Summary of All Diagnostic Modalities Using an Alternative
Gold Standard: Culture Positive or Cytomorphology Positive Plus
Positive Autofluorescence or ZN
Cytology (%) Fluorescence (%) ZN (%) Culture (%)
Sensitivity 78 67 62 75
Specificity 91 97 97 100
PPV 93 97 97 100
NPV 73 66 63 72
Efficacy 83 79 76 84
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ing in identifying mycobacterial infection with a sensitiv-
ity of 67% and a specificity of 97%. Its specificity is
dependant on the experience of the operator and, as ZN
staining, it cannot differentiate between the various myco-
bacteria.20 These results may be partly due to the high
incidence of mycobacterial disease in South Africa and
good clinical selection of patients.
Culture, where feasible and affordable, is an important
part of the investigation of suspected mycobacterial
lymphadenitis. Direct inoculation into MGIT or BactecTM
medium at the bedside gives a high yield,14 but it takes
1–6 weeks for a result, and fails to differentiate the vari-
ous mycobacteria unless additional PCR-based testing is
available for accurate speciation of M. tuberculosis com-
plex. Culture has inherent problems and may be influ-
enced by many factors such as inefficient sampling, con-
tamination, variable bacterial load, and commencement of
therapy prior to the diagnostic procedure. If the cytomor-
phology is consistent with mycobacterial infection, and
the organism is identified by ZN staining or autofluores-
cence, the probability of a false positive diagnosis is
small, and patients may safely commence therapy. FNAB
of superficial lymph nodes is an outpatient procedure and
requires little infrastructure and equipment and is there-
fore ideal for resource-limited countries, which are the
very same countries that bear the burden of HIV and TB.15
The basic diagnostic modalities of cytomorphology and
subsequent morphological identification of the organism
are readily available and relatively inexpensive. Although
culture adds to the cost of the diagnosis, its value lies in
providing an opportunity for speciation and sensitivity
testing, as well as surveillance of prevalent strains within
a community. Although radiometric methods such a
MGIT have reduced the time to culture mycobacterial
organisms, this may still be unacceptably long for patients
who have difficulty in returning for results. Other innova-
tive methods for diagnosing TB are being developed but
remain mainly experimental and are still relatively expen-
sive.21
Most children referred with suspected mycobacterial
lymphadenitis have a tuberculin skin test performed and
must return to the clinic for this to be read with in 48–72
hours. If FNAB is performed at the time of the first visit,
the results of the aspirate can be available at the return
visit 48 hours later. This enables children to be put on
appropriate therapy with a high degree of certainty, pend-
ing the results of culture and speciation. In countries
where culture is not available, FNAB provides the clini-
cian with the ability to make a definitive diagnosis based
on cytomorphology and identification of the organism,
particularly in immune compromised children, who
require urgent and appropriate treatment. If cytology serv-
ices are not available, children with suspected mycobacte-
rial lymphadenopathy may have an FNAB performed and
smears made for direct TB microscopy. Although this is
not ideal, it provides reasonable diagnostic accuracy, with
the additional option to courier-fixed slides to a center
with adequate cytology services. This will help health
care workers in TB-endemic countries with limited
resources to navigate the diagnostic minefield of persistent
lymphadenopathy in children.
In conclusion, FNAB proved highly feasible and pro-
vided a rapid and definitive diagnosis in the majority of
cases, irrespective of the diagnostic modality used.
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 SUMMARY 
Fine needle aspiration biopsy (FNAB) offers a simple outpatient technique for specimen 
collection in paediatric tuberculosis (TB) suspects with peripheral lymphadenopathy. Culture 
facilities are usually centralized; to perform FNAB with mycobacterial culture on an 
outpatient basis requires use of a sterile transport medium to facilitate bedside inoculation, 
maintain organism viability and reduce contamination risk en route to the laboratory. 
We compared the mycobacterial yield and time to positive culture following bedside 
inoculation into standard MGIT tubes versus initial inoculation into an inexpensive “in house” 
liquid growth medium used for transport to the laboratory followed by immediate and delayed 
MGIT inoculation (laboratory inoculation).  
Over the period of one year 150 FNAB’s were performed; 57 (38%) cultured M. tuberculosis 
complex. There was one case each of NTM and M bovis BCG, with the remaining 55 being M 
tuberculosis. Results were concordant in 142 (94.7%) bedside and laboratory inoculation 
pairs.  There was no significant difference in time to positive culture between the bedside and 
laboratory inoculation tubes (16.2 days S.D. 0.87 versus 17.1 days S.D. 0.85). There were 31 
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pairs with matched immediate and delayed laboratory inoculation culture results, of which 29 
were concordant (93.6 %).  The 2 discordant pairs showed no growth in the delayed culture; 
both had required repeated decontamination due to bacterial contamination introduced in the 
laboratory.  
The use of inexpensive “in house” liquid growth medium transport bottles, combined with 
practical tuition in FNAB, will improve cost effective diagnosis of TB at primary health care 
level. 
 
INTRODUCTION 
Tuberculosis (TB) may be extrapulmonary in 10-30% children,1 and TB lymphadenitis is the 
most common extra-pulmonary manifestation of TB in endemic areas;2 5-10% of children 
may have TB adenitis in association with pulmonary involvement. 3 This provides an 
excellent opportunity to obtain bacteriologic confirmation using fine needle aspiration biopsy 
(FNAB).4  FNAB is a simple and safe outpatient procedure that can be performed by nurses in 
resource-limited settings5 and provides material for direct microscopy as well as culture and 
susceptibility testing. Cultures from FNAB specimens in children give a greater yield in a 
shorter time, compared to conventional respiratory specimens such as gastric washings.6 
 
Direct bedside inoculation of FNAB specimens is ideal and excellent results have been 
obtained with commercial liquid media systems such as Mycobacterial Growth Indicator 
Tubes (MGIT, Beckton Dickinson, USA).4  This practice however, is limited by cost and 
availability.4  We aimed to develop a simple and cheap mycobacterial transport medium and 
then to compare the bacteriologic yield and time to positive culture achieved with direct 
bedside inoculation into MGIT versus initial use of the transport medium.  
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MATERIALS AND METHODS 
All adults and children referred to the FNAB Clinic at Tygerberg Hospital, Cape Town, South 
Africa (June 2007-May 2008) with clinical mycobacterial lymphadenitis and in whom written 
informed consent to participate in the study was obtained (following ethics approval) were 
included.  
 
TB transport bottles, containing 1 ml aliquots of Middlebrook 7H9 broth  (with 0.2% glycerol 
and 0.05% Tween 80 added) in 10ml headspace glass vials, were prepared “in-house” 
(Biomedical TB Research Unit by a study scientist, KGPH) in a laminar flow cabinet, sealed 
with 20mmTFE/Sil Septa and 20mm Aluminium open top seals and autoclaved at 120º C / 
20min (Figure 1). Unlike the MGIT tube, the transport bottle does not require removal of the 
lid, minimizing the risk for contamination. 
 
FNAB was done following standard protocol.4  Two needle passes were performed: from the 
first, cytology slides were prepared before the syringe and needle were rinsed by withdrawing 
an aliquot of liquid growth media into the syringe and then expelling the contents back into 
the MGIT tube (bedside inoculation or control). After transport to the laboratory within the 
same hospital, within 2-24 hours, the MGIT tube was incubated in a BACTEC MGIT 960 
machine for 42 days.  
 
From the second FNAB pass, slides were prepared for cytology and the syringe and needle 
were rinsed into the TB transport bottle. In the laboratory, 0.5ml was aspirated from the 
transport bottle, inoculated into a separate MGIT tube (immediate laboratory inoculation) and 
incubated as above.  In a subset of consecutive samples, the transport bottle was held at room 
temperature (12-30 deg Celsius) for 7 days after which subculture was performed as described 
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above (delayed laboratory inoculation). The delayed inoculation group was designed to mimic 
the situation of rural clinics where specimens may take some days to reach the laboratory. 
 
PANTA antibiotic mixture (containing polymixin B, amphotericin B, nalidixic acid, 
trimethoprim and azlocillin) (Becton Dickinson, New York, NY, USA) was added to all 
MGIT tubes before incubation. All positive MGIT tubes were confirmed to contain acid fast 
bacilli in the absence of bacterial contamination, followed by accurate polymerase chain 
reaction (PCR) speciation .7 The mycobacterial yield and time to positive culture in the 
respective MGIT tubes were compared using Statistica Version 8 software and the Chi2 test.    
  
RESULTS 
Over the period of one year 150 FNAB’s were performed, and 24.5% of these were in patients 
less than 16 years, the youngest being 5 months old. M. tuberculosis complex was cultured in 
57 patients (38%). There was one case each of NTM and M bovis BCG, with the remaining 55 
being M tuberculosis; consistent with the profile of disease in our population.3, 4, 8  In the TB 
culture negative patients there were an additional 12 cases (11.4%) positive on cytology 
(morphological evidence of mycobacterial infection and identification of the organism). In 17 
patients there was a specific diagnosis other than mycobacterial infection, made on cytology, 
13 of these malignant neoplasms.  
Results of culture were concordant in 142 (94.7%) bedside and laboratory inoculation pairs, 
with 8 discordant pairs: 3 were positive on bedside inoculation only and 5 were positive on 
laboratory inoculation only.  In one of the discordant pairs, positive on bedside inoculation 
and negative on laboratory inoculation there was inadequate material on the cytology slides. 
There was no significant difference in time to positive culture between the bedside and 
laboratory inoculation tubes (16.2 days S.D. 0.87 versus 17.1 days S.D. 0.85).  
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There were 31 pairs with matched immediate and delayed laboratory inoculation culture 
results, of which 29 were concordant (93.6 %).  The 2 discordant pairs showed no growth in 
the delayed culture, compared to growth in bedside and immediate laboratory cultures; both 
had required repeated decontamination due to bacterial contamination introduced in the 
laboratory. There was no significant difference in time to positive culture between the 
immediate and delayed laboratory inoculation groups (Table 1). 
 
DISCUSSION 
Although FNAB has been shown to be an excellent method for obtaining specimens for 
culture as well as cytology, the method for transporting specimens to the laboratory is rarely 
specified.9   Mycobacteria need to remain viable during transportation if culture is to be 
successful and traditional methods for  the preservation of specimens , e.g. refrigeration10 are 
not applicable to FNAB specimens in resource- poor settings.  In most patients FNAB yields 
insufficient material to express into a sterile tube, and commercial liquid culture media, e.g. 
BACTECTM MYCO/F LYTIC are recommended only for blood and body fluids.11 
Submission of the syringe (with or without the needle attached) directly to the laboratory 
compromises the quality of the specimen and puts health care workers at risk.  This practice is 
unacceptable, especially in settings with a high prevalence of MDR TB and/or HIV. 
 
 Rinsing the needle and syringe in commercial liquid culture medium, such as MGIT, is very 
successful in obtaining a positive culture.4, 5  However, the widespread distribution of MGIT 
tubes is limited by issues of cost and storage requirements. These tubes need to be stored in 
the dark and removal of the cap for inoculation outside the laboratory increases the risk for 
contamination. This study suggests that subculture from a TB transport bottle, even after a 7 
day delay, gives similar yields in a similar time period, to direct bedside inoculation.   The 
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few discrepancies (8/150) noted between the bedside and laboratory cultures may be due to 
random sampling differences as the tubes were inoculated from separate needle passes.   
  
The transport medium described in this study is inexpensive (MGIT tube $4 vs. $1 TB 
transport bottle, 2008 prices in South Africa), easy to prepare “in house”, does not require 
refrigeration as it is stable through a range of temperatures, and does not require removal of 
the lid for inoculation. Transport of these specimens from rural clinics may follow the same 
route as other laboratory specimens such as sputum and peripheral blood.  The positive 
culture yield and the time to positive culture from the transport medium, even after 7 days at 
room temperature, are statistically comparable to direct bedside inoculation into MGIT tubes. 
The production and distribution of these bottles to clinics and hospitals, combined with 
practical tuition in the optimal performance of FNAB, will have a positive impact on the cost 
effective diagnosis of TB at primary health care level. 
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What is already known about this topic. 
FNAB is used as to diagnose suspected mycobacterial lymphadenopathy. 
Mycobacteria may be seen on staining FNAB material, but this does not allow speciation (TB 
or non-tuberculous mycobacteria) or antimicrobial sensitivity testing.  
What this study adds 
A simple and inexpensive means to obtain mycobacterial culture from FNAB specimens was 
developed using an “in house” liquid growth medium for transport to the laboratory. 
Transporting FNAB material to the laboratory in the “in house” medium was similar to a 
commercial medium with respect to culturing mycobacteria and in time to positive culture. 
Similar results were obtained when the ‘in house” transport bottle was kept at room 
temperature for 7 days before culturing for mycobacteria. 
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Table 1 
The mycobacterial yield and time to positive culture achieved with fine needle aspiration 
biopsy and variable timing of MGIT* inoculation  
 
Mycobacterial culture  Time to positive culture 
 
Timing of MGIT* 
inoculation  
Total no 
specimens Positive 
 
Negative Mean 
days 
Standard 
deviation 95% CI
# 
Bedside  vs. immediate laboratory inoculation from transport bottle 
Bedside  150 53 (35.3%) 97 (64.7%) 16.2 0.87 16.8 - 20.3 
Immediate laboratory  150 55 (36.7%) 95 (63.3%) 17.1 0.85 15.7-19.1 
Subset - matched pairs: delayed vs. immediate laboratory inoculation  from transport bottle 
31 11 (35.5%) 20 (64.5%) 17.1 1.36 14.1-20.1 Delayed laboratory  
(day 7) 
Immediate laboratory  
(day 0) 
31 13 (41.9%) 18 (58.1%) 16.2 1.31 13.3-19.2 
 
*MGIT- Mycobacterial Growth Indicator Tube 
#CI- Confidence Interval 
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 Figure 1. TB Transport Bottle 
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Combining Fine Needle Aspiration Biopsy (FNAB) and High Resolution Melt Analysis 
to reduce diagnostic delay in Mycobacterial Lymphadenitis 
 
CA Wright,1* KGP Hoek,2  BJ Marais,3  P van Helden,2 RM Warren,2 
Division of Anatomical Pathology ,Department of Pathology, Stellenbosch University and 
NHLS Tygerberg, South Africa; NRF Centre of Excellence in Biomedical Tuberculosis 
Research / MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology 
and Human Genetics, Stellenbosch University, South Africa; 2 and Department of Pediatrics 
and Child Health, Stellenbosch University, South Africa. 
 
ABSTRACT 
Tuberculous lymphadenitis is the most common cause of extra-pulmonary tuberculosis (TB) 
in developing countries.  Lymphadenitis caused by non-tuberculous mycobacteria (NTM) 
requires consideration, particularly in immunocompromised patients and children in 
developed countries. Fine Needle Aspiration Biopsy (FNAB) offers a valuable specimen 
collection technique, but culture confirmation, mycobacterial speciation and drug resistance 
testing (if indicated) is often unavailable in TB endemic areas and result in unacceptable 
diagnostic delay.  
We evaluated the diagnostic value of high-resolution DNA melting (HRM) analysis in 
the diagnosis of mycobacterial lymphadenopathy using FNAB and an inexpensive transport 
medium. 
Specimens were collected from patients referred to the FNAB Clinic at Tygerberg 
Hospital (June 2007-May 2008) with clinical mycobacterial lymphadenitis.  Cytology, culture 
and HRM were performed on all specimens. The reference standard for disease was defined 
as positive cytology (morphological evidence plus mycobacterial visualization) and/or a 
positive culture   
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Specimens were collected from 104 patients and mycobacterial disease was confirmed 
in 54 (51.9 %); 46 M tuberculosis, 1 M. Bovis BCG, 1 NTM, and 8 not speciated.   Cytology 
was positive in 83.3 % (45 /54) and culture in 72.2 % (39/54) of patients. HRM identified 
57.4 % (31/54) of cases.   Using the defined reference standard we recorded 51.9 % sensitivity 
and 94.0 % specificity (positive predictive value 90.3%) with HRM analysis.   
HRM analysis allowed rapid and species specific diagnosis of mycobacterial lymph 
adenitis in the majority of patients, permitting early institution of appropriate therapy. 
Optimization of this technique requires further study. 
 
INTRODUCTION 
Resource limited countries carry the brunt of the global tuberculosis (TB) epidemic, 
particularly those affected by the parallel human immunodeficiency virus (HIV) pandemic.1 
According to the most recent World Health Organisation (WHO) estimates, in 2007 there 
were 9.3 million incident (newly diagnosed) TB cases of whom 1.4 million (14.8%) were 
HIV-infected.  The African region accounted for 79% of HIV-infected TB cases.1 Although 
TB incidence rates seem to plateau and/or decline in most regions, absolute numbers continue 
to rise due to increases in population size.  The projected scale of the epidemic and ongoing 
transmission of drug resistant TB remains alarming.1 WHO estimated that between 2000 and 
2010 1 billion people will be newly infected with M. tuberculosis, resulting in 200 million TB 
cases and 35 million deaths.2 
Peripheral lymphadenitis is the most common extra-pulmonary manifestation of TB.3-4 
TB lymphadenitis is also the most common cause of persistent cervical lymphadenopathy in 
children from TB endemic areas.5-7 In developed countries where the incidence of TB is low, 
non-tuberculous mycobacteria (NTM) are frequently responsible for mycobacterial 
lymphadenitis, particularly in children and HIV-infected immune compromised adults.3, 8-9 In 
patients with a peripheral lymph node mass fine needle aspiration biopsy (FNAB) is a 
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valuable and underutilized specimen collection technique.  This simple and safe procedure 
allows rapid confirmation of mycobacterial disease using cytomorphology and direct 
mycobacterial visualization with either Ziehl-Neelsen (ZN) staining or fluorescence 
microscopy.  
Mycobacterial culture is required for accurate species determination (speciation) and 
drug susceptibility testing, 10-13 since organisms in the M. tuberculosis complex are 
morphologically indistinguishable. The amount of material harvested during FNAB is 
minimal, and the needle needs to be rinsed at the bedside in liquid medium to facilitate 
culture. Although FNAB can be safely performed as an outpatient procedure by well trained 
nurses 14, the need for direct inoculation and unavailability of liquid culture tubes limited 
decentralization.  Use of an inexpensive transport medium for direct inoculation has been 
described,15 which should facilitate mycobacterial culture from FNAB’s performed in rural 
clinics and hospitals.  Direct bedside inoculation at the time of FNAB collection provides an 
excellent diagnostic yield but culture results may take up to 6 weeks and requires additional 
speciation.10, 16 
Performing nucleic acid amplification tests (NAATs) on FNAB specimens may 
provide a rapid species specific diagnosis and expedite access to appropriate therapy. A recent 
systematic review demonstrated highly variable results with NAATs to diagnose TB 
lymphadenitis, reported sensitivities ranged between 2-100% (specificities 28-100%).17  Most 
NAATs analyze the polymerase chain reaction (PCR) products by gel electrophoresis or other 
open tube formats, which afford the opportunity for laboratory cross contamination. These 
technically challenging techniques will pose problems in countries with limited laboratory 
resources.  High resolution DNA melt analysis (HRM) is a simple “closed-tube” technique 
that reduces the risk of cross contamination.  Specific PCR amplicons are identified according 
to their characteristic DNA melting profile.   The amplicons are combined with a saturating 
dye that fluoresces in the presence of double stranded DNA. It is heated through a range of 
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temperatures while fluorescence is monitored. 18 As the double stranded DNA dissociates 
(melts) into single strands the fluorescence decreases.  The melting peak of the specific 
infectious agent is identified.  The amplicon specific for  M.tuberculosis melt at 90.5°C and 
other members of the M.tuberculosis complex at 86°C.  This simple technique can be used in 
routine diagnostic laboratories.18-19 
The aim of our study was to evaluate the value of PCR-based HRM analysis,18 to 
provide a rapid and accurate diagnosis of mycobacterial disease using routinely collected 
FNAB specimens directly inoculated into liquid transport medium. 
 
MATERIALS AND METHODS 
All adults and children referred to the FNAB Clinic at Tygerberg Hospital (June 2007-May 
2008) with a superficial lymph node mass suggestive of possible mycobacterial lymphadenitis 
and in whom written informed consent to participate in the study was obtained, were 
included.  
Specimen Collection 
FNAB was done following standard protocol as an outpatient procedure by a pathologist.10 
The lymph node was stabilized by the aspirator and two needle passes were performed using a 
23g or 25g needle attached to a 10 ml syringe while applying a constant suction of no more 
than 2 ml. From each aspirate two smears were prepared: one fixed with commercial cytology 
fixative for Papanicolaou staining and the other air dried for the Giemsa and subsequent ZN 
staining. The residual material in the syringe and needle was collected by withdrawing an 
aliquot of liquid growth media from the TB transport bottle into the syringe and then 
expelling the contents back into the bottle. No additional needle passes were performed to 
collect material for microbiology or PCR. The TB transport bottles were prepared “in-house” 
in a laminar flow cabinet: 10ml headspace glass vials containing 1 ml of Middlebrook 7H9 
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broth  (with 0.2% glycerol and 0.05% Tween 80 added), sealed with 20mmTFE/Sil Septa and 
20mm Aluminium open top seals and autoclaved at 120º C for 20min.20  
Cytology 
Stained smears were evaluated for adequacy and to make a morphological diagnosis. If any 
specific lesion such as a lymphoepithelial cyst or neoplasia was present, this was reported.  
Alternatively we reported “non-specific reactive lymphadenopathy” or “cytologically 
consistent with mycobacterial infection”, based on specific morphological criteria.21-23 In 
immunocompetent patients with TB, epithelioid granulomata and epithelioid histiocytes may 
be identified in a background of reactive lymphocytes and plasma cells (Fig 1). A small 
amount of amorphous necrosis may also be identified. In immunocompromised patients, the 
cytological picture is that of abundant necrosis in which neutrophils and cellular debris are 
prominent (Fig 2). In patients with lymphadenitis due to M bovis BCG or NTM infection, 
histiocytes with abundant foamy cytoplasm may be present.8, 24-25 
Mycobacteria were visualized using a ZN stain performed on a Giemsa stained slide 
according to a slightly modified technique (Fig 3). Smears were differentiated in 3% acid 
alcohol for one minute and counterstained with 1% methylene blue for 10 seconds only. In 
addition, one of the Papanicolaou stained slides was screened using a Zeiss Axiophot 
microscope with a fluorescent attachment and a wide-band blue excitation filter (450–480 
nm); mycobacteria fluoresce as brilliant yellow bacilli, thin and slightly curved with polar 
enhancement and a uniform length of 2.0 –2.7 microns (Fig 4).11 
Microbiology 
In the laboratory, 0.5ml of the media was aspirated from the TB transport bottle, inoculated 
into a separate MGIT tube containing the PANTA antibiotic mixture and incubated in a 
BACTEC MGIT 960 machine for 42 days.  All positive MGIT tubes were confirmed to 
contain acid fast bacilli in the absence of bacterial contamination by ZN staining. 
Mycobacteria were identified as M. tuberculosis or other by standard PCR.26  
93
Extraction of mycobacterial DNA  
The TB transport bottles containing the remaining 0.5ml media were stored at -20°C until 
further analysis. Mycobacteria within a 250µl aliquot were pelleted by centrifugation at full 
speed (14 000rpm) for 10 minutes. The supernatant was discarded and the bacterial pellet was 
resuspended in 1ml phosphate buffered saline and re-centrifuged at full speed (14 000rpm) to 
remove residual blood. Thereafter the bacterial pellet was resuspended in 30µl ddH2O and 
heat inactivated at 100°C for 20 minutes. The lysed bacterial extract was stored on filter paper 
(FTA® Classic Card Collection, Storage and Purification system, Whatman, UK). Genomic 
DNA was eluted from the filter paper cards following manufacturers’ instructions (high pH, 
low pH protocol) and served as the template for subsequent PCR amplification. 
Speciation and HRM Analysis 
Primers were designed to amplify the Region of Deletion 9 (RD9), present in M. tuberculosis 
and M. canetti, but absent from all other members of the M. tuberculosis complex. PCR was 
performed as previously described 19 using an annealing temperature of 62°C and the 
following primers RD9Fs1 5’-CAA GTT GCC GTT TCG AGC C-3’, RD9FR 5’-GCT ACC 
CTC GAC CAA GTG TT-3’ and RD9INT 5’-CAA TGT TTG TTG CGC TGC-3’. 27  
Resulting amplification products underwent HRM analysis in a RotorgeneTM6000 real-time 
rotary analyzer (Corbett Life Science, Australia).  The thermal denaturation profiles were 
measured as previously described.19  The infectious agent was identified by the Rotorgene 
TM6000 software according to the presence of derivative melt peaks located within defined 
temperature bins. M. tuberculosis PCR products melt at 90°C (M. tuberculosis could not be 
differentiated from M. canettii, but M. canettii is very rarely observed and has not been 
recorded in the study setting) while PCR products of other members of the M. tuberculosis 
complex melted at 86°C. (Fig.4) 
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Reference standard for mycobacterial disease 
The reference standard for the presence of mycobacterial disease17 was defined as positive 
cytology (morphology consistent with mycobacterial infection plus direct visualization of the 
organism) and/or positive culture with speciation.  
Statistical Analysis 
We assessed the diagnostic accuracy of PCR-based HRM analysis compared to cytology, 
mycobacterial culture and the reference standard as defined using Pearson’s chi-square (X2) 
and Fisher’s exact tests.28 All analyses were conducted using Statistica Version 8.29  Ethics 
approval was obtained from the Institutional Review Board of Stellenbosch University 
(N05/03/043).  
 
RESULTS 
FNAB specimens were collected from 104 patients with possible mycobacterial 
lymphadenitis in whom complete cytopathology and mycobacterial culture results were 
available together with PCR-based HRM analysis. The median age was 30 years with a range 
from 4 months to 62 years. Children less than 13 years of age compromised 21.2 % of the 
study population. There was no significant difference in gender distribution.  HIV status was 
known in 46.1% of patients (48 /104) and 75% of these were HIV positive (36/48). There 
were 23 HIV-positive patients and 6 HIV negative patients with mycobacterial disease as 
defined by the reference standard above. Table 1 summarizes the demographics and 
diagnostic outcome of the study population. 
Applying the defined reference standard 54 of the 104 patients (51.8 %) were 
diagnosed with mycobacterial lymphadenitis.  Mycobacterial culture was positive in 39/54 
(72.2 %) patients; 37 M. tuberculosis, one M. bovis BCG and one NTM. The child with M. 
bovis BCG was less than two years old; four others in this age group were positive for M. 
tuberculosis.  Cytology was positive in 83.3.9 % (45/54) of the cases. Cytology and culture 
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were both positive in 30/54 (55.6%) cases, while HRM analysis was positive in 57.4 % 
(31/54) of cases identified using the reference standard. The calculated sensitivity of HRM 
analysis was 51.9 % and the specificity 94.0 % (Fig 2) with a negative predictive value of 
64.4 % and a positive predictive value of 90.3 % (Fig 5). Concordance between the different 
diagnostic modalities and HRM analysis was poor, with Kappa values of 0.39 vs. cytology, 
0.27 vs. mycobacterial culture, 0.19 vs. both cytology and culture, and 0.45 vs. cytology 
and/or culture (the defined reference standard).  
To investigate a possible association between mycobacterial load and the result of 
PCR-based HRM analysis we tested for any correlation between the time to positivity (TTP, 
often used as a surrogate of mycobacterial load) and PCR outcome.  Among those with 
positive mycobacterial cultures no correlation between the time to positivity and PCR-based 
HRM analysis could be demonstrated; mean TTP in PCR positive cases was 18 days 
compared to 22 days in PCR negative cases (p=0.22).( Fig 5) 
 
DISCUSSION 
With global coordination of control efforts TB incidence rates seem to be stabilizing and 
showing signs of decline in all six world regions.  However, the TB disease burden in areas 
plagued by the concurrent HIV pandemic remains at unprecedented levels.1 Although there is 
some assistance for the development of strong laboratory networks in developing countries, 
the existing infrastructure remains poor in most TB endemic areas.  South Africa, despite its 
relatively good infrastructure and health care services, in 2007 reported a national TB 
incidence of 739.6/100,000 population and an adult TB incidence in the Western Cape 
Province, a high burden region, of 1005.7 /100.000.30  
In TB endemic areas with ongoing transmission, children constitute a significant 
percentage of the total caseload, estimated at 15-20%.31 Immune immaturity and/or 
compromise, most often due to HIV infection,32-33 influence the risk to develop extra 
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pulmonary and/or disseminated TB as well as the likelihood of rapid disease progression and 
TB-related mortality.34-35 Autopsy studies in Africa 33, 36-39 have shown that up to 54% of 
deaths in HIV-infected adults and 20% in HIV-infected children are due to TB. Reducing this 
mortality and morbidity necessitates early detection, efficient diagnosis and timely institution 
of appropriate therapy. 
FNAB is a simple, non-invasive specimen collection technique in patients with 
peripheral lymph node masses 10.  It assists with rapid diagnosis of mycobacterial disease, but 
also helps to rule out alternative diagnoses that may require urgent treatment such as 
neoplasia.  Diagnostic sensitivity is dependent on the experience of the pathologist and for 
mycobacterial disease varies from 32-78%.10, 40-41 Identification of the organism is essential 
particularly in immune compromised patients, as other opportunistic infections such as fungal 
organisms may elicit a similar morphological reaction pattern. Mycobacteria may be 
visualized using ZN staining, which is a very simple stain but has suboptimal sensitivity (20-
62%).10, 17, 42-43 Autofluorescence, using the ability of mycobacteria on Papanicolaou stains 
smears to fluoresce using a blue excitation filter requires no additional staining and improves 
sensitivity (65-67%).10-11 Culture is often regarded as the “gold standard”, but is limited by 
poor sensitivity (reported to be as low as 2-34%) 41, 44 and is highly dependent on the culture 
medium and inoculation technique used. A positive result is delayed by 1-6 weeks and 
requires additional PCR-based testing for speciation. 
Direct NAAT application provides results in 3 to 6 hours and has been evaluated with 
respiratory and non-respiratory specimens such as FNAB’s.17, 43-47 Test sensitivity with 
respiratory specimens is highly dependent on mycobacterial load and use current PCR-based 
tests are only advised in patients with sputum smear-positive TB.  Results with extra-
pulmonary disease have been variable but recent studies have shown excellent results.  Use of 
a nested PCR in cervical TB lymphadenitis in Mexican children showed a sensitivity of 96% 
and a specificity of 93%,47 whilst a study utilizing DNA from dried and fixed cytology smears 
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showed a sensitivity of 85% and specificity of 95% using nested PCR, although reference 
standards are not necessarily based on bacteriological confirmation of disease.48  
The majority of these studies use agarose gel electrophoresis to visualize the products, which 
is not practical in a busy microbiology laboratory.  The open tube nature of the procedure also 
allows the release of amplicons, which pose a real risk of cross-contamination.  A recent 
systematic review evaluating the diagnostic utility of NAATs in TB lymphadenitis identified 
36 peer reviewed publications.17 The authors found marked variation in populations, test 
techniques, reference standards, volume of material utilized and quality indicators. Few 
studies controlled for cross contamination and inhibitors in clinical samples, thereby 
increasing the possibility of both false positive and false negative results. The reference 
standard used most frequently was culture, although the authors regard the sensitivity of 
culture from FNAB to be about 62%.  Using an imperfect reference standard may lead to an 
underestimation of test performance and this is a major limitation that is rarely 
acknowledged.49   
The current study attempted to address some of the shortcomings noted above. The 
reference standard used is a combination of positive cytology, defined as cytomorphological 
features consistent with mycobacterial infection combined with identification of the organism 
using ZN staining or autofluorescence and/or positive culture. The residual material from the 
fine needle aspirates was collected in TB transport medium in a sealed bottle, minimizing the 
possibility of contamination. After washing and concentration of the specimen the pellets 
were placed on filter paper for storage and to remove inhibitors present in the specimen.  
After extraction of DNA, the products were amplified using primers designed to amplify the 
Region of Deletion 9 (RD9), present in M. tuberculosis and M. canetti, but absent from all 
other members of the complex.19 The amplified products were then identified using high 
resolution melt analysis, which is a closed tube format that minimizes the possibility of cross-
contamination. 
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This technique is rapid and simple, and the equipment required for the HRM such as 
the Rotorgene 6000TM real-time rotary analyzer (Corbett Life Science, Australia) is relatively 
inexpensive. Up to 72 samples may be processed in a cycle which takes approximately 3 
hours. 
The results of PCR using this technique did not differ significantly from that of 
cytology or culture when these were assessed independently against the reference standard. 
The sensitivity is relatively low, but the specificity is high at 94% as is the PPV of 90%. This 
enables appropriate therapy to be implemented early with a high degree of confidence in the 
majority of patients with disease, while continuing with culture in the PCR negative cases. 
 
Limited sample volume may have accounted for the low sensitivity observed.  No 
additional needle passes or aspirates were performed and the material collected was limited to 
the residual amount left in the needle. Sensitivity may be improved if an additional needle 
pass is performed to obtain material for PCR. No single diagnostic modality was adequately 
sensitive to enable it to be used alone. FNAB provides material for cytology, culture and PCR 
using the transport medium described. This is of particular value in resource limited countries 
where laboratories tend to be centralized.1 Cytology slides once prepared are stable at room 
temperature, as is the transport medium where the mycobacterial organism has been shown to 
remain viable for up to 7 days at room temperature, enabling both culture and PCR. 20  
Ideally, the PCR technique could be refined, increasing the sensitivity and thereby 
eliminating the need for culture, which is costly and lengthy. Use of the transport bottle 
facilitates both culture and PCR analysis, but material may be deposited directly onto filter 
paper for subsequent PCR analysis.  Refined techniques need to remain simple inexpensive 
and appropriate for use in routine laboratories in countries with limited resources and skills 
that bear the burden of this devastating and persistent disease. 
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 Table 1 
Demographics and diagnostic outcome  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Numbers Percentage 
Number of cases 104  
Age  
< 2 years 6 5.8 
<13 years 22 21.2 
> 13 years 77 74 
Unknown 5 5 
Gender  
Male 48 46.2. 
Female 51 49.0 
Unknown 5 4.8 
HIV status  
Positive 36 34.6 
Negative 12 11.5 
Unknown 56 53.9 
Cytodiagnoses  
Malignancy 12 11.5 
Reactive node  43 41.4 
Other (e.g. cyst) 4 3.9 
Cytology positive mycobacterial infection 45 43.3 
Cases with mycobacterial disease  
Culture and/or cytology positive (Reference Std) 54 100 
Cytology positive  45 83.3 
Culture positive  39 72.2 
Culture positive and cytology positive 30 55.6 
PCR positive mycobacterial infection 31 57.4 
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Figure 1. Epithelioid granuloma in an immune competent patient. (Papanicolaou, x400) 
 
 
Figure 2. Abundant necrosis in which neutrophils and cellular debris are prominent 
consistent with tuberculous lymphadenitis in an immune compromised patient.  
(Papanicolaou, x400) 
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Figure 3. Modified ZN stain in a lymph node aspirate. (Ziehl-Neelson, x400)  
 
 
Figure 4. Autofluorescence of mycobacteria in a lymph node aspirate.  
(Papanicolaou, x1000 with a wide-band blue excitation filter) 
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Fig 5 Rotorgene software depicting the derivative melt peaks located within defined 
temperature bins. M.tuberculosis products melted at 90°C and M.tuberculosis complex at 
86°C. 
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CHAPTER 7 
 
CONCLUSION 
 
The aim of this dissertation was to demonstrate the value of Fine Needle Aspiration Biopsy in 
the diagnosis of mycobacterial lymphadenitis with particular reference to children.  
Mycobacterial disease in children poses a particular diagnostic and management 
problem. It is a major cause of childhood morbidity and mortality in developing countries, 
where it is under reported due to problems in obtaining an accurate diagnosis. The traditional 
methods used to diagnose tuberculosis (TB) in adults are not feasible in children under the age 
of 7-8 years, young children experience the greater disease burden and a significant 
percentage (~10%) of children have extra pulmonary disease manifestations only. 
Clinical criteria and chest radiography have diagnostic limitations which are compounded in 
children who are HIV infected. In young children and in those with HIV/AIDS, early 
diagnosis is essential, as dissemination may occur rapidly due to their immature or 
compromised immune system. 
We first established that TB lymphadenitis is a common clinical problem in children 
in TB endemic areas and that FNAB is an efficient, simple and effective diagnostic modality 
in determining the cause of lymphadenopathy in children.  
We showed that FNAB provides superior diagnostic yields and a significant reduction 
in time to diagnosis when compared with conventional laboratory specimens in children. 
Autofluorescence was demonstrated to be an accurate, rapid and inexpensive method 
for demonstrating mycobacteria on routinely stained cytology smears and this was confirmed 
in a prospective study in children where FNAB was shown to provide a rapid and definitive 
diagnosis in the majority of cases with TB lymphadenitis.  
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We developed a new reference standard for mycobacterial disease using FNAB - 
positive cytology (cytomorphological evidence of disease and identification of the organism) 
and/or positive culture. 
Lymphadenopathy induced by BCG vaccination needs to be distinguished from TB 
lymphadenitis. Although not central to this thesis, a small study during this time period 
demonstrated cytomorphological features on FNAB which may assist in distinguishing 
between these two organisms, together with clinical features. (See Appendix A) 
Although cytomorphology may confirm mycobacterial disease, organisms in the M 
tuberculosis complex are morphologically indistinguishable. This requires submission of 
material for culture and subsequent speciation or submission of material for direct PCR. 
As FNAB yields a miniscule amount of material, immediate bedside inoculation is required 
for culture. We developed an inexpensive liquid transport medium which facilitated culture 
from FNAB specimens, in which organisms remain viable for up to 7 days at room 
temperature. This is particularly useful in resource limited countries where laboratories are 
centralised and transport of specimens may be problematical. 
Culture for speciation of mycobacterial organisms takes up to 6 weeks and this may 
result in inappropriate treatment or delayed commencement of therapy. Using the transport 
medium developed we established a rapid simple and inexpensive technique using PCR and 
High Resolution Melt Analysis, which is feasible for implementation in routine diagnostic 
laboratories. 
In summary, the outcome of these studies has demonstrated the need for, and value of,  
FNAB in the diagnosis of mycobacterial lymphadenitis particularly in children in TB endemic 
areas. 
We have improved the ability of cytology to confirm mycobacterial disease using 
autofluorescence. We have developed a means to obtain a culture from FNAB using a novel 
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transport medium and have developed a simple nucleic acid amplification technique which 
will enable rapid confirmation and speciation of mycobacterial disease. 
There are many challenges that remain, but we are working to develop an even simpler 
technique for collecting material from FNAB for PCR/HRM analysis which would provide 
higher sensitivity by removing inhibitors in the sample. 
 
Conventional fluorescent microscopy using mercury vapour lamps is expensive and 
therefore not feasible in resource-limited countries, and we intend to demonstrate the utility of 
inexpensive rewindable LED light sources in autofluorescence and auramine stained FNAB 
smears. A retrospective comparative study has already been completed. (see addendum A) 
The quest to find and establish the ideal modality for diagnosing mycobacterial 
disease has been a long one for many researchers. The many clinical manifestations of this 
elusive disease and the reality that it is a disease that affects the poor and less influential 
segments of the global population compounds the problem. 
Currently a lot of attention is focused on identifying improved methods for TB 
diagnosis. The field is ever-changing and no sooner has a technique been optimised when it is 
evident that a better methodology has emerged. We hope that this research has contributed a 
small step towards success in the fight against this devastating disease. 
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REFLECTIVE ASSESSMENT OF CONTRIBUTION. 
 
In summary this thesis makes the following theoretical, empirical and methodological 
contributions to the literature. 
 
Theoretical contribution:   
FNAB is utilised in adult patients in neoplastic and infectious diseases,  and to a lesser extent  
in paediatric oncology, but it potential contribution in paediatrics is not sufficiently 
appreciated. These results demonstrate the utility of FNAB in the diagnosis of TB, especially 
in children. The studies show that FNAB is equal to or superior to conventional diagnostic 
specimen types in children and that it is accurate, easy to perform, and yields rapid diagnostic 
information. 
 
Empirical contribution:  
Countries with low economic resources and high healthcare resource constraints bear the 
brunt of TB and HIV infections. This body of research demonstrates that FNAB can be 
implemented in these settings in the diagnosis of mycobacterial disease in children. It shows 
how FNAB and a novel transport medium solve problems in the collection of material for 
culture and NAAT, and autofluorescence assists in the cytological diagnosis of mycobacterial 
disease.  
 
Methodological contribution: 
The methodologies and concepts used in this thesis have been developed specifically for 
utilisation in resource limited countries.  
A new method of NAAT on FNAB material is developed and its benefits assessed. 
This new method is appropriate for use in resource limited countries. Although NAAT’s have 
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been used in the diagnosis of mycobacterial disease on FNAB, the results are extremely 
variable and impractical for implementation in routine diagnostic laboratories. The new 
method utilises high resolution DNA melt analysis was developed which is rapid inexpensive, 
minimises contamination and is applicable for implementation in routine diagnostic 
laboratories. This was performed on specimens collected in the mycobacterial transport 
medium. 
A novel transport medium was developed to facilitate mycobacterial culture from 
FNAB specimens, particularly in rural hospitals and clinics. Autofluorescence is used in the 
research as an additional inexpensive and rapid means of bacteriological confirmation of 
mycobacterial disease on cytology smears, which was not previously published. This was then 
applied to fine needle aspirates in children with mycobacterial disease. 
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“I am not discouraged, because every wrong attempt discarded is another step forward” 
Thomas A. Edison 
 
I hope that this body of research will help others remember the inestimable honour we all 
have in serving humankind by undertaking research into the diseases plaguing our nation. All 
of us have an invaluable and unique role to play from the clinicians in their day-to-day contact 
with patients experiencing the frustration of practical problems associated with diagnosis and 
management of disease, to the biomedical scientists with out whose expertise solutions would 
not be possible. It is through collaboration and commitment to a common goal that we will 
achieve the Millennium Developmental Goal 6 of reducing the prevalence and death rate from 
tuberculosis by 2015 through early diagnoses of new cases. 
 
The primary, the most urgent requirement is the promotion of education. It is inconceivable 
that any nation should achieve prosperity and success unless this paramount, this 
fundamental concern is carried forward. The principal reason for the decline and fall of 
peoples is ignorance. Today the mass of the people are uninformed even as to ordinary 
affairs, how much less do they grasp the core of the important problems and complex needs of 
the time. 
  
It is therefore urgent that beneficial articles and books be written, clearly and definitely 
establishing what the present-day requirements of the people are, and what will conduce to 
the happiness and advancement of society. These should be published and spread throughout 
the nation, so that at least the leaders among the people should become, to some degree, 
awakened, and arise to exert themselves along those lines which will lead to their abiding 
honor. The publication of high thoughts is the dynamic power in the arteries of life; it is the 
very soul of the world. Thoughts are a boundless sea, and the effects and varying conditions 
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of existence are as the separate forms and individual limits of the waves; not until the sea 
boils up will the waves  rise and scatter their pearls of knowledge on the shore of life. 
  
  (Abdu'l-Baha, The Secret of Divine Civilization, p. 108) 
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